{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":184,"total_is_capped":false,"direct_labels_cover":2,"predictions_cover":184,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"43ac0f224e9c","filters":{"venue":"Future Oncology"}},"results":[{"id":"W2339030197","doi":"10.2217/fon-2016-0130","title":"ROBUST: Lenalidomide-R-Chop Versus Placebo-R-Chop in Previously Untreated Abc-Type Diffuse Large B-Cell Lymphoma","year":2016,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Lenalidomide; Medicine; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Clinical endpoint; Lymphoma; Oncology; Placebo; Pathology; Clinical trial; Multiple myeloma","authors":[{"name":"Grzegorz S. Nowakowski","is_ca":false},{"name":"Annalisa Chiappella","is_ca":false},{"name":"Thomas E. Witzig","is_ca":false},{"name":"Michele Spina","is_ca":false},{"name":"Randy D. Gascoyne","is_ca":true},{"name":"Lei Zhang","is_ca":false},{"name":"Jocelyne Flament","is_ca":false},{"name":"Jacqueline Repici","is_ca":false},{"name":"Umberto Vitolo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02435570999588384,"gpt":0.2834791903245364,"spread":0.2591234803286526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003180841,0.0004353379,0.00086998,0.0002436433,0.0001057217,0.00001951111,0.0002001416,0.0005842641,0.0007496884],"category_scores_gemma":[0.0002024379,0.0002701633,0.0002024968,0.0004347922,0.00009475267,0.0001139879,0.0001130504,0.0001438355,0.0009097147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002059813,"about_ca_system_score_gemma":0.0007126404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001476172,"about_ca_topic_score_gemma":0.001093302,"domain_scores_codex":[0.9973329,0.0002353896,0.0005285006,0.0007054918,0.0002894056,0.0009082848],"domain_scores_gemma":[0.997981,0.0006534774,0.0002028384,0.0006440457,0.0001480253,0.0003706724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1206294,0.08726981,0.2430457,0.0005055662,0.001993947,0.01724965,0.004189384,0.0000159528,0.01138249,0.005073534,0.2453374,0.2633072],"study_design_scores_gemma":[0.3477148,0.004864604,0.05373899,0.0002459192,0.0005085582,0.0002528578,0.0003677272,0.00003685527,0.002848873,0.00003487313,0.5889038,0.0004820589],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9684504,0.0024292,0.00001029768,0.006883131,0.002154956,0.001119693,0.00003714648,0.0001530741,0.01876215],"genre_scores_gemma":[0.9905221,0.002550527,0.0004343421,0.001192497,0.00102244,0.0002075565,0.00006568826,0.00006694995,0.003937884],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3435664,"threshold_uncertainty_score":0.9999751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896248377","doi":"10.2217/fon-2018-0711","title":"Sequential treatment with afatinib and osimertinib in patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer: an observational study","year":2018,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Osimertinib; Afatinib; Medicine; T790M; Observational study; Internal medicine; Lung cancer; Oncology; Clinical trial; Chemotherapy; Retrospective cohort study; Cancer; Epidermal growth factor receptor; Erlotinib; Gefitinib","authors":[{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Alessandro Morabito","is_ca":false},{"name":"Desirée Hao","is_ca":true},{"name":"Cheng‐Ta Yang","is_ca":false},{"name":"Ross A. Soo","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Rasim Gucalp","is_ca":false},{"name":"Balázs Halmos","is_ca":false},{"name":"Lara Wang","is_ca":false},{"name":"Amanda Golembesky","is_ca":false},{"name":"Angela Märten","is_ca":false},{"name":"Tanja Čufer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0245710663428718,"gpt":0.3572036998636381,"spread":0.3326326335207663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005086075,0.0002166178,0.0003311389,0.0000935446,0.0001466334,0.0000169894,0.00004273032,0.00008863971,0.00009078532],"category_scores_gemma":[0.000002286654,0.0001409517,0.00001949275,0.0002134451,0.00009452903,0.0001268505,0.00001419929,0.00009981366,0.00000303652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006624966,"about_ca_system_score_gemma":0.0008531549,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001125043,"about_ca_topic_score_gemma":0.007527696,"domain_scores_codex":[0.9988894,0.00007379366,0.0002192189,0.0004069592,0.0001781917,0.0002324725],"domain_scores_gemma":[0.9992224,0.00004122679,0.0001393364,0.0001674786,0.0002958187,0.0001337349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002394323,0.003769702,0.9725625,0.00001950042,0.000442968,0.0001024189,0.01228831,0.00002003723,0.00005398092,0.00002255178,0.0001170263,0.008206679],"study_design_scores_gemma":[0.02598287,0.03109554,0.9378313,0.00005448252,0.000955864,0.00001286458,0.002318929,0.0001301562,0.0002227426,0.000003319398,0.001227327,0.0001646358],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946372,0.0001125193,0.00005178423,0.0007815619,0.0002060827,0.002279411,0.00007798448,0.00002442752,0.001829038],"genre_scores_gemma":[0.995282,0.00001554244,0.002231317,0.0006199363,0.0005138072,0.0005613299,0.0004558837,0.0000292882,0.0002909107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03473123,"threshold_uncertainty_score":0.5747845,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4366236771","doi":"10.2217/fon-2022-1196","title":"Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i> -mutant breast cancer during first-line treatment","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"AstraZeneca","keywords":"Medicine; Mutant; Breast cancer; Oncology; Cancer; Line (geometry); Internal medicine; Cancer research; Genetics; Biology; Gene","authors":[{"name":"Nicholas C. Turner","is_ca":false},{"name":"Cynthia Huang Bartlett","is_ca":false},{"name":"Kevin Kalinsky","is_ca":false},{"name":"Massimo Cristofanilli","is_ca":false},{"name":"Giampaolo Bianchini","is_ca":false},{"name":"Stephen Chia","is_ca":true},{"name":"Hiroji Iwata","is_ca":false},{"name":"Wolfgang Janni","is_ca":false},{"name":"X. Cynthia","is_ca":false},{"name":"Erica L. Mayer","is_ca":false},{"name":"Yeon Hee Park","is_ca":false},{"name":"Stephen B. Fox","is_ca":false},{"name":"Xiaochun Liu","is_ca":false},{"name":"Sasha McClain","is_ca":false},{"name":"François‐Clément Bidard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03019315399695848,"gpt":0.354143198096221,"spread":0.3239500440992625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002196447,0.0002560923,0.001065533,0.0002765761,0.00004739554,0.000002387458,0.0001058276,0.0001949615,0.0001399339],"category_scores_gemma":[0.00001555314,0.0001979508,0.0001281947,0.000552772,0.00007630509,0.00006785778,0.00003307494,0.0002108678,0.000003552724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000703231,"about_ca_system_score_gemma":0.0005938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001066119,"about_ca_topic_score_gemma":0.001317394,"domain_scores_codex":[0.9982646,0.0001074969,0.0006742477,0.0003373473,0.0002134104,0.0004029151],"domain_scores_gemma":[0.9989976,0.0001748686,0.0003368353,0.0002967924,0.0000882298,0.0001056175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4075116,0.002989146,0.0006983898,0.0003919741,0.0005624729,0.0008909811,0.007959361,0.006322346,0.3861565,0.00004201126,0.00002956683,0.1864457],"study_design_scores_gemma":[0.8866469,0.01343199,0.006895936,0.001028574,0.0006137905,0.000752871,0.002886276,0.001617002,0.0790986,0.0002145662,0.006299309,0.0005142461],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924985,0.0006492788,0.0006742883,0.003741739,0.0007445539,0.001430919,0.0001181146,0.0000761308,0.0000664811],"genre_scores_gemma":[0.9961213,0.001523325,0.0006920916,0.00007510644,0.001081946,0.0003098269,0.00002280217,0.00004334655,0.0001302806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4791353,"threshold_uncertainty_score":0.8072198,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3012293314","doi":"10.2217/fon-2020-0044","title":"MIRROS: A Randomized, Placebo-Controlled, Phase III Trial of Cytarabine ± Idasanutlin in Relapsed or Refractory Acute Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Cytarabine; Myeloid leukemia; Refractory (planetary science); Internal medicine; Placebo; Oncology; Randomized controlled trial; Myeloid; Pathology","authors":[{"name":"Pau Montesinos","is_ca":false},{"name":"Benjamin M. Beckermann","is_ca":false},{"name":"Olivier Catalani","is_ca":false},{"name":"Jordi Esteve","is_ca":false},{"name":"Katia Gamel","is_ca":false},{"name":"Marina Konopleva","is_ca":false},{"name":"Giovanni Martinelli","is_ca":false},{"name":"Annabelle Monnet","is_ca":false},{"name":"Cristina Papayannidis","is_ca":false},{"name":"Aaron Park","is_ca":true},{"name":"Christian Récher","is_ca":false},{"name":"Rebeca Rodríguez‐Veiga","is_ca":false},{"name":"Christoph Röllig","is_ca":false},{"name":"Norbert Vey","is_ca":false},{"name":"Andrew H. Wei","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Pierre Fenaux","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02589568544120383,"gpt":0.3477053238999175,"spread":0.3218096384587137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002664284,0.0005248872,0.004723516,0.0005064848,0.00007537776,0.00001448527,0.0004852675,0.001046344,0.001776293],"category_scores_gemma":[0.003186089,0.00035911,0.000623839,0.0008956362,0.00051723,0.0001133897,0.0001937828,0.002086558,0.0001463242],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001983862,"about_ca_system_score_gemma":0.005715582,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001969036,"about_ca_topic_score_gemma":0.00016548,"domain_scores_codex":[0.994016,0.001581616,0.002015001,0.0008308835,0.0007222727,0.0008342284],"domain_scores_gemma":[0.9953237,0.002426984,0.0007347366,0.0006363766,0.0002860965,0.000592076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9368089,0.001131992,0.000006092655,0.0001404567,0.0009252265,0.002551056,0.001983457,0.0000110721,0.0225974,0.0001452237,0.02459714,0.009102022],"study_design_scores_gemma":[0.8974115,0.01363606,0.000007499333,0.00007082944,0.0007894085,0.0001634441,0.0007497107,0.003182622,0.001067593,0.00003189383,0.08261053,0.0002788886],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9449093,0.001093969,0.0002253899,0.03115807,0.001142593,0.01253603,0.00007783485,0.0001794992,0.008677267],"genre_scores_gemma":[0.9629622,0.003614001,0.006628453,0.009326775,0.007870532,0.002677107,0.0004176801,0.000218166,0.006285098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05801339,"threshold_uncertainty_score":0.9999211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134027539","doi":"10.2217/fon-2020-1264","title":"CDK4/6 Inhibitors in HR+/HER2- Advanced/metastatic Breast Cancer: A Systematic Literature Review of Real-World Evidence Studies","year":2021,"lang":"en","type":"review","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Medicine; Oncology; Metastatic breast cancer; Internal medicine; Breast cancer; Trastuzumab; Real world evidence; Cancer; Gynecology","authors":[{"name":"Nadia Harbeck","is_ca":false},{"name":"Meaghan Bartlett","is_ca":true},{"name":"Dean Spurden","is_ca":false},{"name":"Becky Hooper","is_ca":true},{"name":"Lin Zhan","is_ca":false},{"name":"Emily Rosta","is_ca":true},{"name":"Chris Cameron","is_ca":true},{"name":"Debanjali Mitra","is_ca":false},{"name":"Anna Zhou","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06187251663254414,"gpt":0.4556644636025236,"spread":0.3937919469699794,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00126664,0.001164902,0.01387891,0.0008266321,0.0000617195,0.00001610483,0.0004915693,0.0004915995,0.0001983257],"category_scores_gemma":[0.0008220832,0.0008115508,0.001131825,0.00390862,0.0003085603,0.0002610857,0.0002471821,0.001697328,0.00001802858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003433783,"about_ca_system_score_gemma":0.003160235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003577475,"about_ca_topic_score_gemma":0.0006079005,"domain_scores_codex":[0.9923388,0.001867416,0.003190952,0.001173329,0.0007094197,0.0007200618],"domain_scores_gemma":[0.9928809,0.001642899,0.002776559,0.00133251,0.001136526,0.0002305938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.00006192512,0.0001322083,0.0000101737,0.5988708,0.000842752,0.0008415221,0.0003280346,6.587494e-7,0.000001261924,0.00009184145,0.001160068,0.3976588],"study_design_scores_gemma":[0.0004992508,0.0001901177,0.0000105147,0.5758204,0.003359602,0.00209453,0.0003451907,1.628828e-7,7.59632e-7,0.00001278873,0.4173443,0.0003223988],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001696495,0.9889974,0.000002831855,0.002760088,0.002200201,0.005445968,0.0002589224,0.00007226325,0.0002606094],"genre_scores_gemma":[0.000001859528,0.9905137,0.001803049,0.001102822,0.001596423,0.003552785,0.0001439219,0.0001614059,0.001124052],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4161842,"threshold_uncertainty_score":0.9994335,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138368669","doi":"10.2217/fon.15.251","title":"Current State of Biomarkers in Ovarian Cancer Prognosis","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston General Hospital; Queen's University","funders":"","keywords":"Medicine; Ovarian cancer; Carboplatin; Paclitaxel; Tumor microenvironment; Disease; Drug resistance; Oncology; Chemotherapy; Cancer; Serous fluid; Internal medicine; Bioinformatics; Cisplatin; Biology","authors":[{"name":"Katrina Au","is_ca":true},{"name":"Juliana Alves Josahkian","is_ca":false},{"name":"Julie‐Ann Francis","is_ca":true},{"name":"Jeremy A. Squire","is_ca":false},{"name":"Madhuri Koti","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07496433028108566,"gpt":0.4302141523516914,"spread":0.3552498220706057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000358762,0.000416945,0.002987758,0.0004044071,0.00001499412,0.000005470462,0.0001485093,0.0003444594,0.0001987153],"category_scores_gemma":[0.00002104067,0.0002898111,0.0003940088,0.0006160852,0.00008227392,0.0000259994,0.00006882827,0.0004745612,0.00003295451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001967811,"about_ca_system_score_gemma":0.004496917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002048322,"about_ca_topic_score_gemma":0.0006241944,"domain_scores_codex":[0.9977921,0.0002401493,0.0008316871,0.000524656,0.0002447104,0.0003666868],"domain_scores_gemma":[0.9986016,0.00009201274,0.0005747785,0.0003665265,0.0001463748,0.0002187484],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008324492,0.0009469806,0.0007486064,0.01200434,0.001078675,0.0001733462,0.0001158757,1.578052e-7,8.036235e-8,0.00004130315,0.01548901,0.9693184],"study_design_scores_gemma":[0.002053507,0.0006674083,0.001051424,0.0130878,0.002411854,0.00004863289,0.00001112403,4.650679e-7,0.000001461756,0.00002537062,0.9804366,0.0002043919],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001333824,0.9921514,0.000001014658,0.001267565,0.002486948,0.002189031,0.0002844228,0.00001791045,0.001588349],"genre_scores_gemma":[0.00001704503,0.9965738,0.0003497779,0.00005905069,0.0009489468,0.00170173,0.0002322734,0.00005552026,0.00006185438],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.969114,"threshold_uncertainty_score":0.9999554,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3082658746","doi":"10.2217/fon-2020-0740","title":"Sequential Afatinib and Osimertinib in Patients with <i>EGFR</i> Mutation-Positive Non-Small-Cell Lung Cancer: Final Analysis of the GioTag Study","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Boehringer Ingelheim","keywords":"Afatinib; Osimertinib; Medicine; Lung cancer; Internal medicine; Oncology; T790M; Clinical trial; Cancer; Adenocarcinoma; Erlotinib; Epidermal growth factor receptor","authors":[{"name":"Maximilian J. Hochmair","is_ca":false},{"name":"Alessandro Morabito","is_ca":false},{"name":"Desirée Hao","is_ca":true},{"name":"Cheng‐Ta Yang","is_ca":false},{"name":"Ross A. Soo","is_ca":false},{"name":"James Chih‐Hsin Yang","is_ca":false},{"name":"Rasim Gucalp","is_ca":false},{"name":"Balázs Halmos","is_ca":false},{"name":"Angela Märten","is_ca":false},{"name":"Tanja Čufer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01026167357481095,"gpt":0.3128247802196673,"spread":0.3025631066448563,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004487096,0.0001274778,0.0004024151,0.00009041099,0.00006410906,0.000006023568,0.00006270648,0.00006696203,0.00006690063],"category_scores_gemma":[0.000009559428,0.00007948541,0.00006339502,0.0007218148,0.00005332015,0.00003367054,0.00003582297,0.0001536122,5.761471e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001681992,"about_ca_system_score_gemma":0.0003794078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005228427,"about_ca_topic_score_gemma":0.001531869,"domain_scores_codex":[0.9991128,0.00008571818,0.0002435068,0.0002588398,0.0001603267,0.0001388437],"domain_scores_gemma":[0.9994278,0.00004985617,0.0001847455,0.000125375,0.0001357461,0.00007646895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007811188,0.0008855312,0.9796025,0.00004058264,0.001720887,0.00003227924,0.01437947,0.0003544364,0.00008736172,0.000008081589,0.0002275642,0.001880239],"study_design_scores_gemma":[0.009511874,0.002129287,0.9781771,0.00002720027,0.006860887,0.00000105079,0.002196195,0.0005187364,0.0001918533,7.467892e-7,0.0003047362,0.00008037357],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946353,0.0001987892,0.00003892967,0.00269572,0.0001289135,0.001251358,0.00009448544,0.000007863936,0.0009486511],"genre_scores_gemma":[0.9982992,0.00001299686,0.0002357455,0.001071129,0.0001142002,0.000104013,0.00008695325,0.00001156784,0.00006418373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01218328,"threshold_uncertainty_score":0.3241321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068549807","doi":"10.2217/fon.14.208","title":"Dovitinib (CHIR258, TKI258): Structure, Development and Preclinical and Clinical Activity","year":2015,"lang":"en","type":"article","venue":"Future Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Sorafenib; Platelet-derived growth factor receptor; Tyrosine-kinase inhibitor; Receptor; Pharmacology; VEGF receptors; Receptor tyrosine kinase; Cancer research; Tyrosine kinase; Oncology; Cancer; Internal medicine; Growth factor; Hepatocellular carcinoma","authors":[{"name":"Camillo Porta","is_ca":true},{"name":"Palma Giglione","is_ca":true},{"name":"Wanda Liguigli","is_ca":false},{"name":"Chiara Paglino","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06228528774817588,"gpt":0.404677689405457,"spread":0.3423924016572811,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006696468,0.0001831283,0.0003149247,0.00004033979,0.00007124243,0.00002315541,0.0001969038,0.0006497463,0.00001896927],"category_scores_gemma":[0.0005508382,0.0001546711,0.00004435047,0.00005673539,0.000311708,0.000006242332,0.0006188701,0.0004150815,0.000009177131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003669244,"about_ca_system_score_gemma":0.0005541631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009806578,"about_ca_topic_score_gemma":0.000401957,"domain_scores_codex":[0.9982708,0.0003603731,0.0003072672,0.0005666674,0.0001645702,0.0003303899],"domain_scores_gemma":[0.9989755,0.0001043669,0.00009948989,0.0003081688,0.0000992645,0.0004132586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005068912,0.0007135253,0.3680168,0.0001328558,0.0005298816,0.00009496544,0.0004372992,0.000001632994,0.08371187,0.0004424597,0.04582447,0.4950253],"study_design_scores_gemma":[0.0027075,0.002312828,0.2000365,0.000008334062,0.00002069503,0.000145504,0.0001196063,0.0000247993,0.0162348,0.0001581407,0.7779499,0.000281498],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962174,0.0005052194,0.00006330344,0.001020845,0.0005362993,0.0002368026,0.00001949732,0.0000158053,0.001384862],"genre_scores_gemma":[0.9915535,0.0001247908,0.006217896,0.0003156878,0.00143509,0.00001166303,0.0000548726,0.00002385039,0.0002626451],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7321253,"threshold_uncertainty_score":0.6307305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4292884011","doi":"10.2217/fon-2022-0595","title":"HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Zymeworks (Canada); Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Trastuzumab; Internal medicine; Chemotherapy; Oncology; Gastroesophageal Junction; Monoclonal antibody; Cancer; Adenocarcinoma; Antibody; Immunology; Breast cancer","authors":[{"name":"Josep Tabernero","is_ca":false},{"name":"Lin Shen","is_ca":false},{"name":"Elena Elimova","is_ca":true},{"name":"Geoffrey Y. Ku","is_ca":false},{"name":"Tianshu Liu","is_ca":false},{"name":"Kohei Shitara","is_ca":false},{"name":"Xiao Lin","is_ca":false},{"name":"Lisa Boyken","is_ca":true},{"name":"Huiyan Li","is_ca":false},{"name":"Jonathan Grim","is_ca":true},{"name":"Jaffer A. Ajani","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01669934964258832,"gpt":0.2941696805263527,"spread":0.2774703308837643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001103118,0.000226455,0.0006778278,0.0001461192,0.0001512271,0.000005924986,0.0001551107,0.0000903848,0.001286832],"category_scores_gemma":[0.00001118133,0.0002001999,0.0002528299,0.0002269674,0.00007365236,0.00003887336,0.0001213782,0.0001470125,0.00001072798],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001084303,"about_ca_system_score_gemma":0.0002627469,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008684387,"about_ca_topic_score_gemma":0.00005103938,"domain_scores_codex":[0.9985757,0.00007208415,0.0003323778,0.0003863935,0.000239507,0.0003939226],"domain_scores_gemma":[0.9991966,0.00009286123,0.0001994645,0.0003402439,0.00006070356,0.0001101095],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02588986,0.008106522,0.09516451,0.0007613979,0.002719479,0.003112798,0.007239022,0.00005141295,0.003787126,0.007008407,0.2307851,0.6153743],"study_design_scores_gemma":[0.02222334,0.04139117,0.1677056,0.00001471414,0.001045296,0.0004872588,0.004086863,0.00008605092,0.002263776,0.0001178523,0.7603283,0.0002498346],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8731357,0.01094708,0.002623729,0.05833946,0.008792704,0.009933133,0.001887819,0.0003838367,0.03395658],"genre_scores_gemma":[0.9849302,0.0001247513,0.005330961,0.001103621,0.001781418,0.0006220394,0.0007924488,0.000049059,0.005265516],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6151245,"threshold_uncertainty_score":0.9996261,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2795150236","doi":"10.2217/fon-2018-0121","title":"Accelerating Drug Development in Pediatric Cancer: A Novel Phase I Study Design of Venetoclax in Relapsed/Refractory Malignancies","year":2018,"lang":"en","type":"article","venue":"Future Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Celgene; Sanofi; Genentech; Ariad Pharmaceuticals; Amgen","keywords":"Venetoclax; Medicine; Clinical trial; Refractory (planetary science); Oncology; Internal medicine; Drug development; Chronic lymphocytic leukemia; Chemotherapy; Cancer; Drug; Leukemia; Pharmacology","authors":[{"name":"Andrew E. Place","is_ca":false},{"name":"Kelly C. Goldsmith","is_ca":false},{"name":"Jean‐Pierre Bourquin","is_ca":false},{"name":"Mignon L. Loh","is_ca":false},{"name":"Lia Gore","is_ca":false},{"name":"Daniel A. Morgenstern","is_ca":true},{"name":"Yeshwant D. Sanzgiri","is_ca":false},{"name":"David Hoffman","is_ca":false},{"name":"Ying Zhou","is_ca":false},{"name":"Jeremy A. Ross","is_ca":false},{"name":"Betty Prine","is_ca":false},{"name":"Mohamad Shebley","is_ca":false},{"name":"Megan McNamee","is_ca":false},{"name":"Thalia A. Farazi","is_ca":false},{"name":"Su Young Kim","is_ca":false},{"name":"Maria Verdugo","is_ca":false},{"name":"L. Leanne Lash-Fleming","is_ca":false},{"name":"C. Michel Zwaan","is_ca":false},{"name":"Josef Vormoor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06121352229830328,"gpt":0.3801271580229051,"spread":0.3189136357246018,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00120617,0.0001987876,0.0006129741,0.0004835558,0.00005566327,0.000006589269,0.0002236838,0.0002157349,0.0001773267],"category_scores_gemma":[0.0002326879,0.0001737872,0.00003377618,0.0007892459,0.0001115192,0.00005568104,0.0001390193,0.0004479092,0.00002017352],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02193918,"about_ca_system_score_gemma":0.03192395,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001271013,"about_ca_topic_score_gemma":0.004896155,"domain_scores_codex":[0.9977221,0.0002212224,0.0007051741,0.000421199,0.0004013403,0.0005289494],"domain_scores_gemma":[0.9988522,0.0003291037,0.0002027132,0.0002967517,0.0002021657,0.0001170701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.02843801,0.03889183,0.3072578,0.002845262,0.0006840225,0.006648735,0.2872058,0.002066146,0.1160149,0.0003617849,0.02043066,0.1891551],"study_design_scores_gemma":[0.5678964,0.03589468,0.2487631,0.001164238,0.0004529454,0.0005036509,0.02965404,0.02052747,0.03428456,0.00006213223,0.05902417,0.001772636],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959479,0.00113446,0.00007485264,0.0002110458,0.000470319,0.00150178,0.000002914062,0.00002275884,0.0006339901],"genre_scores_gemma":[0.9929671,0.0001720689,0.004804692,0.000153952,0.001221497,0.0003384243,0.000005538974,0.00003079092,0.0003059063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5394584,"threshold_uncertainty_score":0.9818154,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3032832010","doi":"10.2217/fon-2020-0184","title":"Pembrolizumab Given Concomitantly with Chemoradiation and as Maintenance Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: KEYNOTE-412","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Rosetrees Trust; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Pembrolizumab; Head and neck squamous-cell carcinoma; Head and neck; Oncology; Basal cell; Internal medicine; Head and neck cancer; Radiation therapy; Surgery; Immunotherapy; Cancer","authors":[{"name":"Jean‐Pascal Machiels","is_ca":false},{"name":"Yungan Tao","is_ca":false},{"name":"Barbara Burtness","is_ca":false},{"name":"Makoto Tahara","is_ca":false},{"name":"Lisa Licitra","is_ca":false},{"name":"Danny Rischin","is_ca":false},{"name":"John Waldron","is_ca":true},{"name":"Christian Simon","is_ca":false},{"name":"Vincent Grégoire","is_ca":false},{"name":"Kevin J. Harrington","is_ca":false},{"name":"Gustavo Vasconcelos Alves","is_ca":false},{"name":"Iane Pinto Figueiredo Lima","is_ca":false},{"name":"Y. Pointreau","is_ca":false},{"name":"Brett Hughes","is_ca":false},{"name":"Sercan Aksoy","is_ca":false},{"name":"Marcin Hetnał","is_ca":false},{"name":"Joy Yang Ge","is_ca":false},{"name":"Holly Brown","is_ca":false},{"name":"Jonathan D. Cheng","is_ca":false},{"name":"Behzad Bidadi","is_ca":false},{"name":"Lillian L. Siu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0139099776184559,"gpt":0.2772550983325816,"spread":0.2633451207141257,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006203996,0.0002071832,0.0006256194,0.0000295546,0.0001112617,0.000009133338,0.0000507655,0.0001567546,0.00001634385],"category_scores_gemma":[0.00005001579,0.0001508236,0.00004037125,0.0001018479,0.0001333874,0.00005824809,0.00002590281,0.0002006631,0.000003672374],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001105157,"about_ca_system_score_gemma":0.0003279419,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000291313,"about_ca_topic_score_gemma":0.0001011159,"domain_scores_codex":[0.9989688,0.00003271138,0.0001930041,0.0003975817,0.0001024553,0.0003054216],"domain_scores_gemma":[0.9992965,0.0001332076,0.0001036954,0.0001192805,0.0001328244,0.0002144521],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2485461,0.001380754,0.09401625,0.003297301,0.0004377948,0.001450219,0.04219198,0.00004147838,0.06050072,0.002565554,0.08594459,0.4596272],"study_design_scores_gemma":[0.1044553,0.05747252,0.1251927,0.00008436314,0.0001768659,0.0003680726,0.003338193,0.0006214869,0.004817408,0.0001262953,0.7028363,0.0005103901],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9417488,0.008609402,0.0001708905,0.04350508,0.0001703641,0.001050772,0.00002202169,0.0000496472,0.004673028],"genre_scores_gemma":[0.9866399,0.001045783,0.00210836,0.009101905,0.0007041886,0.0001174182,0.00001772976,0.00003206502,0.0002326197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6168917,"threshold_uncertainty_score":0.615041,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4385442656","doi":"10.2217/fon-2023-0228","title":"TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancer","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Triple-negative breast cancer; Internal medicine; Triple negative; Cancer","authors":[{"name":"Rebecca Dent","is_ca":false},{"name":"David W. Cescon","is_ca":true},{"name":"Thomas Bachelot","is_ca":false},{"name":"Kyung Hae Jung","is_ca":false},{"name":"Zhi‐Ming Shao","is_ca":false},{"name":"Shigehira Saji","is_ca":false},{"name":"Tiffany A. Traina","is_ca":false},{"name":"Petra Vuković","is_ca":false},{"name":"Darlington Mapiye","is_ca":false},{"name":"Micah J. Maxwell","is_ca":false},{"name":"Peter Schmid","is_ca":false},{"name":"Javier Cortés","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05001610890154408,"gpt":0.3967505803952925,"spread":0.3467344714937484,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004490214,0.0003096265,0.0007729273,0.0002648612,0.0001951061,0.00001972886,0.0001823382,0.000212198,0.002578821],"category_scores_gemma":[0.0001400729,0.0002270391,0.0001760536,0.0008642035,0.0001624052,0.0001121285,0.00004945621,0.0003985622,0.000161761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009687147,"about_ca_system_score_gemma":0.001961005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001361663,"about_ca_topic_score_gemma":0.0009752177,"domain_scores_codex":[0.9977624,0.0002315718,0.0005086627,0.0005649098,0.0002967505,0.0006357214],"domain_scores_gemma":[0.998248,0.0004934901,0.0002132798,0.0003738301,0.0003956846,0.0002756587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.02129145,0.0008338637,0.0005789305,0.000560217,0.0009585206,0.0003130682,0.002532727,0.00008260553,0.003918598,0.001979566,0.4137519,0.5531985],"study_design_scores_gemma":[0.02718349,0.003744944,0.007734699,0.0004104835,0.0004887836,0.001048102,0.002982462,0.001291625,0.002663691,0.001613897,0.9503112,0.0005266688],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.2597716,0.008221367,0.02310485,0.6072302,0.04288676,0.02552762,0.01422213,0.003489512,0.01554595],"genre_scores_gemma":[0.7269709,0.01776345,0.05472384,0.06098132,0.03573477,0.03005938,0.003695193,0.0009877854,0.06908336],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5526718,"threshold_uncertainty_score":0.998333,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122558264","doi":"10.2217/fon.12.3","title":"The Current Role of Circulating Tumor Cells in the Diagnosis and Management of Bone Metastases in Advanced Prostate Cancer","year":2012,"lang":"en","type":"review","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Circulating tumor cell; Management of prostate cancer; Oncology; Cancer; Prostate-specific antigen; Prostate; Internal medicine; Disease; Disease monitoring; Metastasis","authors":[{"name":"Fred Saad","is_ca":true},{"name":"Klaus Pantel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05575054018666093,"gpt":0.4170604696478369,"spread":0.361309929461176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008706891,0.0002203113,0.001206052,0.0001544811,0.00004068685,0.000005158888,0.0001348883,0.00007712586,0.00001673953],"category_scores_gemma":[0.00001390882,0.0001021244,0.0001369585,0.000404025,0.0001462992,0.00002993932,0.0001085507,0.0004567752,0.00000118144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002700617,"about_ca_system_score_gemma":0.0002752255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006388861,"about_ca_topic_score_gemma":0.000268491,"domain_scores_codex":[0.998151,0.0004377527,0.0005952088,0.0002359151,0.0002306404,0.0003494839],"domain_scores_gemma":[0.9987797,0.000448967,0.0004115737,0.0002660972,0.00004530281,0.00004834316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001016505,0.0003012118,0.0008911734,0.01742276,0.0001649727,0.00007724339,0.0005695487,8.371467e-7,0.000003655611,0.0001293456,0.00009627749,0.9802413],"study_design_scores_gemma":[0.00113688,0.0002167243,0.001213857,0.007729141,0.0008734205,0.00001568298,0.000918587,0.000001148396,0.00002381694,0.00003159659,0.9877528,0.00008634188],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00201075,0.9938769,8.325875e-8,0.0003565868,0.0002714608,0.00301263,0.0001283184,0.00000328037,0.0003399429],"genre_scores_gemma":[0.001812563,0.9952536,0.00007385667,0.0000153214,0.0001450558,0.002585849,0.00005716071,0.00001956123,0.00003706117],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9876565,"threshold_uncertainty_score":0.4164512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3107254051","doi":"10.2217/fon-2020-0655","title":"Dostarlimab in the Treatment of Recurrent or Primary Advanced Endometrial Cancer","year":2020,"lang":"en","type":"review","venue":"Future Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Microsatellite instability; Endometrial cancer; Medicine; DNA mismatch repair; Oncology; Internal medicine; Immune checkpoint; Immune system; Cancer; Cancer research; Immunotherapy; Microsatellite; Immunology; Gene; Genetics; Biology","authors":[{"name":"Lawrence Kasherman","is_ca":true},{"name":"Soha Ahrari","is_ca":true},{"name":"Stéphanie Lheureux","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08592308035728641,"gpt":0.4281559395685617,"spread":0.3422328592112753,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001945323,0.0005164232,0.004220629,0.0003720963,0.00003321697,0.000006199888,0.0002613234,0.000499611,0.0006760914],"category_scores_gemma":[0.0001554322,0.0002286466,0.0008160534,0.001910813,0.00007582454,0.00002567709,0.0000390418,0.0004572535,0.00003035429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002640445,"about_ca_system_score_gemma":0.002197772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009138251,"about_ca_topic_score_gemma":0.0002873381,"domain_scores_codex":[0.9971972,0.0005779067,0.0009411729,0.0005412311,0.0003766709,0.0003658815],"domain_scores_gemma":[0.9973606,0.00149048,0.0005394685,0.0004040782,0.00005789425,0.0001475209],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005303867,0.001889686,0.00001025579,0.004888176,0.0006055539,0.000637543,0.0003240377,5.936564e-8,6.299022e-7,0.00002803491,0.0005424482,0.9857697],"study_design_scores_gemma":[0.01388079,0.01563278,0.00005064281,0.001928558,0.003033492,0.0001024419,0.00009302355,9.032937e-8,0.000002045135,0.000006487063,0.9650972,0.0001724014],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000247425,0.9887264,6.941268e-7,0.001503075,0.002585432,0.003505339,0.000327534,0.0000214924,0.003305272],"genre_scores_gemma":[0.00001049985,0.9927356,0.0002780322,0.0004125524,0.004174019,0.00171922,0.0004249514,0.00004248541,0.0002026574],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9855973,"threshold_uncertainty_score":0.9323938,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996531785","doi":"10.2217/fon.09.26","title":"Role of The<i>MTHFR</i>Polymorphisms in Cancer Risk Modification and Treatment","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada Research Chairs; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Methylenetetrahydrofolate reductase; Single-nucleotide polymorphism; Medicine; Pharmacogenetics; Pharmacology; Antimetabolite; Cancer; Methotrexate; Bioinformatics; Cancer research; Allele; Internal medicine; Genetics; Biology; Genotype; Gene","authors":[{"name":"Young‐In Kim","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05384394065183835,"gpt":0.4075805005562327,"spread":0.3537365599043944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001458903,0.0002016702,0.001197731,0.0001723828,0.00003388717,0.000003246071,0.0001108656,0.0005107351,0.00005834824],"category_scores_gemma":[0.00001966707,0.0001079809,0.0001910268,0.0003050126,0.00008284147,0.00001522486,0.00003243962,0.0004185176,0.000009436604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005853696,"about_ca_system_score_gemma":0.0008219743,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007658069,"about_ca_topic_score_gemma":0.001021186,"domain_scores_codex":[0.9987941,0.0002435713,0.0003495312,0.0002710714,0.0001379416,0.000203755],"domain_scores_gemma":[0.9992269,0.00007772002,0.0002431751,0.0003472585,0.00003873695,0.00006617563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003664107,0.0002476225,0.0002505515,0.0004706648,0.00009416138,0.000009840061,0.0001535533,1.800059e-7,0.0000291785,0.0000549497,0.0003232549,0.9983294],"study_design_scores_gemma":[0.0006947025,0.0008000761,0.004613889,0.001199485,0.0006610205,0.00006068041,0.00003426823,0.000006857731,0.00001506253,0.00002732828,0.9918059,0.0000807211],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001739075,0.9941538,1.074113e-7,0.0006500668,0.0001386941,0.001041568,0.00005215942,0.000007081774,0.002217477],"genre_scores_gemma":[0.0003727576,0.9976658,0.00004509379,0.00005013234,0.0005282871,0.000173225,0.00004070471,0.00001755561,0.001106463],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9982487,"threshold_uncertainty_score":0.4403333,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166859022","doi":"10.2217/fon.09.157","title":"Potential Use of Ultrasound for the Detection of Cell Changes in Cancer Treatment","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":47,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; Toronto Metropolitan University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Ultrasound; Oncology; Cancer; Internal medicine; Radiology","authors":[{"name":"Michael C. Kolios","is_ca":true},{"name":"Gregory J. Czarnota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03504508620806288,"gpt":0.3067117270932862,"spread":0.2716666408852233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004118694,0.0001687611,0.0006748647,0.00008581614,0.00002423676,0.000004128053,0.0001017886,0.0003137694,0.00002179574],"category_scores_gemma":[0.000004318933,0.0001071549,0.0001763282,0.0001434462,0.00002563402,0.00001467341,0.000003468535,0.00011565,0.000001156516],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002295385,"about_ca_system_score_gemma":0.00007650507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009162353,"about_ca_topic_score_gemma":0.002813127,"domain_scores_codex":[0.9994369,0.00003071442,0.0002451352,0.0001181745,0.00003928872,0.0001298017],"domain_scores_gemma":[0.9992589,0.0003964758,0.0001269059,0.0001762822,0.00002447525,0.00001695923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005072227,0.0000729323,6.192054e-7,0.001210528,0.00008439389,3.192849e-7,0.0001014999,0.0002089635,0.001945371,0.0000189308,0.00009109066,0.9962603],"study_design_scores_gemma":[0.0001878045,0.0001832575,0.00002776916,0.0001602545,0.0005733249,0.000009587398,0.0000279044,0.00002627309,0.0003933909,0.000007409512,0.9983162,0.00008679172],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001218619,0.9976621,0.0004477809,0.00003944312,0.0004499145,0.0009619018,0.0002066233,0.00002017992,0.00009024407],"genre_scores_gemma":[0.0009357361,0.9972633,0.000235197,0.000008940078,0.0006188178,0.0007749598,0.0000435883,0.00002591852,0.00009358979],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9982252,"threshold_uncertainty_score":0.4369649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2159471993","doi":"10.2217/14796694.2.6.765","title":"Erbb Receptors and Epithelial-Cadherin–Catenin Complex In Human Carcinomas","year":2006,"lang":"en","type":"review","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Cadherin; Medicine; Receptor; Catenin; ErbB; Cancer research; Signal transduction; Internal medicine; Biology; Cell biology; Cell; Wnt signaling pathway; Genetics","authors":[{"name":"Amber Yasmeen","is_ca":true},{"name":"Tarek A. Bismar","is_ca":true},{"name":"Ala‐Eddin Al Moustafa","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1385490509996071,"gpt":0.4622853322673678,"spread":0.3237362812677608,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006912357,0.0005780958,0.003305819,0.0006102498,0.00009609414,0.00002072334,0.0003419504,0.001451502,0.001220874],"category_scores_gemma":[0.00005729921,0.0004662482,0.0003054508,0.0006115937,0.0004342532,0.00002901033,0.000178023,0.00202952,0.0001784299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00198005,"about_ca_system_score_gemma":0.001580246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006533348,"about_ca_topic_score_gemma":0.001052851,"domain_scores_codex":[0.9962773,0.0007125597,0.0009773178,0.0008594119,0.0003805905,0.000792827],"domain_scores_gemma":[0.9985192,0.0002144078,0.0002991768,0.0005711103,0.00009650674,0.0002995481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003793664,0.0002161854,0.0002462163,0.01055661,0.00008069934,0.0006406705,0.000162156,7.330915e-8,0.00003205761,0.0003788453,0.07405671,0.9135919],"study_design_scores_gemma":[0.001204963,0.0009694896,0.0008142134,0.004062437,0.0003308482,0.0005773322,0.00007001243,8.585548e-7,0.000003254689,0.0000525444,0.9915528,0.0003612898],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002579079,0.9620643,0.000001065869,0.001085162,0.0009791148,0.001874403,0.00008312137,0.00006793749,0.03358697],"genre_scores_gemma":[0.00009160034,0.9885082,0.0005681449,0.000179885,0.004188462,0.0002657312,0.0006641167,0.0001474228,0.005386394],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.917496,"threshold_uncertainty_score":0.9998448,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387950784","doi":"10.2217/fon-2023-0526","title":"TALAPRO-3 Clinical Trial Protocol: Phase III Study of Talazoparib Plus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Medicine; Prostate cancer; Clinical endpoint; Internal medicine; Oncology; Olaparib; Placebo; Androgen deprivation therapy; Clinical trial; Androgen receptor; Cancer; Poly ADP ribose polymerase; Gene; Pathology; Biology; Polymerase","authors":[{"name":"Neeraj Agarwal","is_ca":false},{"name":"Fred Saad","is_ca":true},{"name":"Arun Azad","is_ca":false},{"name":"Joaquı́n Mateo","is_ca":false},{"name":"Nobuaki Matsubara","is_ca":false},{"name":"Neal D. Shore","is_ca":false},{"name":"Jayeta Chakrabarti","is_ca":false},{"name":"Hsiang-Chun Chen","is_ca":false},{"name":"Silvana Lanzalone","is_ca":false},{"name":"Alexander Niyazov","is_ca":false},{"name":"Karim Fizazi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1308447482002217,"gpt":0.5230714336123913,"spread":0.3922266854121696,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001755492,0.0002432696,0.001193719,0.0003122034,0.00006093897,0.000008953164,0.00009997907,0.0002071892,0.0002202963],"category_scores_gemma":[0.0001860126,0.0002063789,0.0001384341,0.0008899193,0.0002003897,0.00009257857,0.00004909299,0.0006165329,0.0000296662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004916751,"about_ca_system_score_gemma":0.001951913,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003168575,"about_ca_topic_score_gemma":0.002285446,"domain_scores_codex":[0.9963118,0.0009024829,0.001447469,0.0005424372,0.0004015002,0.0003943516],"domain_scores_gemma":[0.9982294,0.0004524892,0.000560238,0.0003442137,0.0002601577,0.0001535178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8323759,0.02042129,0.00804625,0.0004330573,0.001217372,0.004172592,0.03046013,0.0007755735,0.008246495,0.0003713613,0.01831354,0.0751664],"study_design_scores_gemma":[0.8883721,0.03797112,0.01049593,0.0001900557,0.0003196014,0.00009138611,0.01528689,0.0008302326,0.002102367,0.0001523455,0.04385009,0.0003379361],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8893812,0.0000211081,0.00001754627,0.001767884,0.001323693,0.1065766,0.00007450112,0.0000938415,0.0007435807],"genre_scores_gemma":[0.8358145,0.00004558908,0.0003233333,0.0005839883,0.001889677,0.160578,0.00008945276,0.00004885143,0.0006265579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07482847,"threshold_uncertainty_score":0.8415886,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4291019728","doi":"10.2217/fon-2022-0484","title":"Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo + Ruxolitinib in JAK Inhibitor Treatment-Naive Myelofibrosis","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Medical Research Council; Rosetrees Trust; Cancer Research UK","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Myeloproliferative neoplasm; Internal medicine; Placebo; Clinical trial; Oncology; Extramedullary hematopoiesis; Bone marrow; Haematopoiesis; Pathology; Stem cell","authors":[{"name":"Claire Harrison","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Aaron T. Gerds","is_ca":false},{"name":"Raajit K. Rampal","is_ca":false},{"name":"Srđan Verstovšek","is_ca":false},{"name":"Moshe Talpaz","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Ruben A. Mesa","is_ca":false},{"name":"Andrew Kuykendall","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Francesca Palandri","is_ca":false},{"name":"Sebastian Grosicki","is_ca":false},{"name":"Timothy Devos","is_ca":false},{"name":"Éric Jourdan","is_ca":false},{"name":"Mariëlle J. Wondergem","is_ca":false},{"name":"Haifa Kathrin Al‐Ali","is_ca":false},{"name":"Veronika Buxhofer‐Ausch","is_ca":false},{"name":"Alberto Álvarez‐Larrán","is_ca":false},{"name":"Andrea Patriarca","is_ca":false},{"name":"Marina Kremyanskaya","is_ca":false},{"name":"Adam J. Mead","is_ca":false},{"name":"Sanjay Akhani","is_ca":false},{"name":"Yuri Sheikine","is_ca":false},{"name":"Gozde Colak","is_ca":false},{"name":"John Mascarenhas","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02084345738915811,"gpt":0.3262002128301859,"spread":0.3053567554410278,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003557414,0.0006118029,0.001365352,0.0004609035,0.0004566811,0.00002982466,0.0001968813,0.0003275333,0.005497203],"category_scores_gemma":[0.00006628998,0.0005244421,0.000328423,0.000514619,0.0001392119,0.00010901,0.0001998161,0.0006782003,0.0002117855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002886561,"about_ca_system_score_gemma":0.0010342,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003731311,"about_ca_topic_score_gemma":0.0004960012,"domain_scores_codex":[0.9961163,0.0005958824,0.0008407882,0.000981,0.0005057428,0.0009602911],"domain_scores_gemma":[0.9980111,0.0005353927,0.0003139203,0.0005697068,0.0001192401,0.0004506592],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1144464,0.1177782,0.1942951,0.0005935633,0.003719964,0.02742101,0.04007006,0.0001237222,0.01071617,0.05464203,0.224584,0.2116098],"study_design_scores_gemma":[0.09103584,0.03152957,0.01785703,0.00007801368,0.0004604751,0.00110888,0.006282044,0.00006997532,0.003775928,0.0001703223,0.8470834,0.0005484995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9432635,0.001172837,0.000003611887,0.01524702,0.001618992,0.002825734,0.0005351236,0.000161153,0.03517202],"genre_scores_gemma":[0.9817665,0.0006236355,0.0009754239,0.003331976,0.002721996,0.004087188,0.001053983,0.0000996196,0.005339665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6224995,"threshold_uncertainty_score":0.9997207,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3119071615","doi":"10.2217/fon-2020-1048","title":"MOMENTUM: Momelotinib Vs Danazol in Patients with Myelofibrosis Previously Treated with JAKi Who Are Symptomatic and Anemic","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sierra Wireless (Canada); Princess Margaret Cancer Centre","funders":"Medical Research Council; Cancer Research UK","keywords":"Myelofibrosis; Medicine; Ruxolitinib; Anemia; Constitutional symptoms; Internal medicine; Bone marrow","authors":[{"name":"Srđan Verstovšek","is_ca":false},{"name":"Chih‐Cheng Chen","is_ca":false},{"name":"Miklós Egyed","is_ca":false},{"name":"Martin Ellis","is_ca":false},{"name":"María Laura Fox","is_ca":false},{"name":"Yeow Tee Goh","is_ca":false},{"name":"Vikas Gupta","is_ca":true},{"name":"Claire Harrison","is_ca":false},{"name":"Jean‐Jacques Kiladjian","is_ca":false},{"name":"Mihaela Lazaroiu","is_ca":false},{"name":"Adam J. Mead","is_ca":false},{"name":"Donal P. McLornan","is_ca":false},{"name":"Mary Frances McMullin","is_ca":false},{"name":"Stephen T. Oh","is_ca":false},{"name":"Andrew C. Perkins","is_ca":false},{"name":"Uwe Platzbecker","is_ca":false},{"name":"Christof Scheid","is_ca":false},{"name":"Alessandro M. Vannucchi","is_ca":false},{"name":"Sung‐Soo Yoon","is_ca":false},{"name":"Mark Kowalski","is_ca":true},{"name":"Ruben A. Mesa","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005068712736830131,"gpt":0.2304273460770635,"spread":0.2253586333402334,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007215623,0.0003420924,0.0009685581,0.0001472062,0.00008330367,0.00002440669,0.00005485377,0.000203524,0.000186513],"category_scores_gemma":[0.00002937675,0.0002201206,0.00004221691,0.0004249785,0.00009167525,0.00008023062,0.00004501418,0.0002315779,0.00001449291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003696101,"about_ca_system_score_gemma":0.0002487873,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003203894,"about_ca_topic_score_gemma":0.0006445913,"domain_scores_codex":[0.9982703,0.0001430806,0.0003318794,0.0005706251,0.0002698331,0.0004142869],"domain_scores_gemma":[0.9989155,0.0001229966,0.0001935469,0.0003263674,0.0002177821,0.0002238069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001511995,0.001515953,0.9888734,0.0002297296,0.0002930254,0.0006273015,0.0008406059,0.000003500581,0.00004273865,0.00009363507,0.001190673,0.004777477],"study_design_scores_gemma":[0.01485766,0.006754275,0.971373,0.0009168236,0.0003685386,0.0001585322,0.0005917839,0.00002056079,0.0009031663,0.000007978944,0.003811434,0.0002362807],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933943,0.000660462,0.000002672867,0.003121975,0.0000623553,0.001221446,0.00003043502,0.00004914241,0.001457213],"genre_scores_gemma":[0.9964492,0.0004519453,0.0009312849,0.0008701131,0.0001236921,0.0003690998,0.000257276,0.00004653439,0.0005008243],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01750041,"threshold_uncertainty_score":0.8976257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059728548","doi":"10.2217/14796694.3.5.575","title":"Role of Dead Box 1 In Retinoblastoma and Neuroblastoma","year":2007,"lang":"en","type":"review","venue":"Future Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Retinoblastoma; Neuroblastoma; Cancer research; Medicine; Pediatric cancer; Gene; Cancer; Biology; Genetics; Internal medicine","authors":[{"name":"Roseline Godbout","is_ca":true},{"name":"Lei Li","is_ca":true},{"name":"Rong‐Zong Liu","is_ca":true},{"name":"Ken Roy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03436796280175208,"gpt":0.3918929967397098,"spread":0.3575250339379578,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002719323,0.0004457246,0.002453023,0.0008240686,0.0000310553,0.000006480798,0.0001674718,0.0007778585,0.000101915],"category_scores_gemma":[0.0001062715,0.0003395523,0.0002931336,0.0005832228,0.0002022126,0.00003574276,0.0001729486,0.001063438,0.00007812054],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002548331,"about_ca_system_score_gemma":0.000742086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002165274,"about_ca_topic_score_gemma":0.00019122,"domain_scores_codex":[0.9974588,0.0003028025,0.0007477434,0.0005878334,0.0003093494,0.0005934751],"domain_scores_gemma":[0.9984265,0.0004158241,0.0003257212,0.0004267258,0.00007729138,0.000327947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003679535,0.0004607308,0.0000798275,0.006943439,0.0001385048,0.002091886,0.00004431729,1.917215e-8,0.00004104726,0.0001469579,0.0005083383,0.989177],"study_design_scores_gemma":[0.001579248,0.003549869,0.0009594745,0.003723094,0.0003704496,0.002645171,0.00004025259,0.000001087825,0.00003585032,0.00002306702,0.9869,0.000172489],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002378426,0.9862987,4.746137e-7,0.0001437595,0.0001963282,0.001229717,0.00003236021,0.00003683388,0.009683381],"genre_scores_gemma":[0.0003098684,0.998047,0.0004398487,0.000122048,0.0004759216,0.00007884452,0.00004342304,0.0000775376,0.0004055068],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9890045,"threshold_uncertainty_score":0.9999056,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4205173478","doi":"10.2217/fon-2021-1096","title":"A Phase III, Randomized, Open-Label Study (CONTACT-02) of Cabozantinib Plus Atezolizumab Versus Second Novel Hormone Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Exelixis","keywords":"Cabozantinib; Medicine; Atezolizumab; Prostate cancer; Enzalutamide; Oncology; Internal medicine; Clinical trial; Cancer; Nivolumab; Immunotherapy; Androgen receptor","authors":[{"name":"Neeraj Agarwal","is_ca":false},{"name":"Arun Azad","is_ca":false},{"name":"Joan Carles","is_ca":false},{"name":"Simon Chowdhury","is_ca":false},{"name":"Bradley A. McGregor","is_ca":false},{"name":"Axel S. Merseburger","is_ca":false},{"name":"Stéphane Oudard","is_ca":false},{"name":"Fred Saad","is_ca":true},{"name":"Andrey Soares","is_ca":false},{"name":"Fawzi Benzaghou","is_ca":false},{"name":"Yannick Kerloëguen","is_ca":false},{"name":"Akiko Kimura","is_ca":false},{"name":"Nehal Mohamed","is_ca":false},{"name":"Ashok Panneerselvam","is_ca":false},{"name":"Fong Wang","is_ca":false},{"name":"Sumanta K. Pal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05788647460081912,"gpt":0.3914232047436411,"spread":0.333536730142822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008006791,0.0002808939,0.001401433,0.0002470112,0.0001825272,0.00002384795,0.0002436563,0.00005761014,0.0007242298],"category_scores_gemma":[0.00002621105,0.0001874587,0.0000612052,0.0005388457,0.0001360969,0.0001424998,0.0001499414,0.0004662986,0.000001412548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008830553,"about_ca_system_score_gemma":0.002188477,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00192255,"about_ca_topic_score_gemma":0.003625285,"domain_scores_codex":[0.9974299,0.0004697815,0.0006429495,0.0004769249,0.0005393412,0.0004410919],"domain_scores_gemma":[0.9986373,0.0002513141,0.0003933377,0.0003181993,0.0002657612,0.0001341104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9560444,0.02329654,0.001216055,0.00004389544,0.001532663,0.00036484,0.008037047,0.0000175712,0.00239451,0.00007664809,0.0005511086,0.006424685],"study_design_scores_gemma":[0.9324665,0.05118962,0.005866837,0.00002281761,0.0003046062,0.000007738914,0.005477837,0.00007845699,0.0001850705,0.000006039159,0.00420829,0.0001861532],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849012,0.002365011,0.000003173764,0.0006627126,0.0004016368,0.01024653,0.0005251385,0.00001572245,0.0008788646],"genre_scores_gemma":[0.9941168,0.0003187351,0.0002781414,0.0001337211,0.00006222759,0.003691825,0.0003519292,0.00004016822,0.001006412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02789309,"threshold_uncertainty_score":0.7929808,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134403963","doi":"10.2217/fon-2020-1269","title":"Belantamab Mafodotin in Combination with Novel Agents in Relapsed/refractory Multiple Myeloma: DREAMM-5 Study Design","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; Vancouver General Hospital","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Oncology; Refractory (planetary science); Carfilzomib; Internal medicine; Pomalidomide","authors":[{"name":"Ajay K. Nooka","is_ca":false},{"name":"Katja Weisel","is_ca":false},{"name":"Niels W.C.J. van de Donk","is_ca":false},{"name":"David Routledge","is_ca":false},{"name":"Paula Rodríguez‐Otero","is_ca":false},{"name":"Kevin Song","is_ca":true},{"name":"Hang Quach","is_ca":false},{"name":"Natalie S. Callander","is_ca":false},{"name":"Monique C. Minnema","is_ca":false},{"name":"Suzanne Trudel","is_ca":true},{"name":"Nicola Jackson","is_ca":false},{"name":"Christoph M. Ahlers","is_ca":false},{"name":"Ellie Im","is_ca":false},{"name":"Shinta Cheng","is_ca":false},{"name":"Lon Smith","is_ca":false},{"name":"Geraldine Ferron‐Brady","is_ca":false},{"name":"Maria Brouch","is_ca":false},{"name":"Rocío Montes de","is_ca":false},{"name":"Sofia Paul","is_ca":false},{"name":"Beata Holkova","is_ca":false},{"name":"Ira Gupta","is_ca":false},{"name":"Brandon E. Kremer","is_ca":false},{"name":"Paul G. Richardson","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.050819269986887,"gpt":0.3395705788726691,"spread":0.2887513088857821,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004494459,0.0002379421,0.0005728211,0.000346706,0.0000657374,0.00001390185,0.0001136353,0.0002548287,0.0001891357],"category_scores_gemma":[0.0002717767,0.0001920897,0.00004728402,0.0006133139,0.00005619299,0.00007730578,0.00008051984,0.0006279177,0.00005238363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008829897,"about_ca_system_score_gemma":0.0007122398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003376213,"about_ca_topic_score_gemma":0.00729917,"domain_scores_codex":[0.9976762,0.0004786832,0.0003804385,0.0005365901,0.0004148675,0.0005131978],"domain_scores_gemma":[0.9988025,0.0003821041,0.0001049537,0.0003630948,0.0001556618,0.0001916246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005265257,0.02221852,0.9288791,0.00005542254,0.0002182484,0.01424548,0.001988886,0.00004207645,0.002934418,0.00005311649,0.0006827302,0.02341676],"study_design_scores_gemma":[0.05627549,0.005217661,0.9297489,0.00008305634,0.00005534574,0.0002725557,0.002900855,0.0005663027,0.0007360177,0.00001428093,0.00396691,0.000162625],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944088,0.0002546021,0.0001887011,0.001341651,0.0002466708,0.001817846,0.00001662825,0.00004012123,0.001684985],"genre_scores_gemma":[0.9942689,0.00005610449,0.004005573,0.0002251694,0.000142547,0.0002494319,0.0001824095,0.00003781081,0.0008320652],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05101024,"threshold_uncertainty_score":0.783319,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2123883580","doi":"10.1517/14796694.1.1.125","title":"Therapeutic implications of DNA methylation","year":2005,"lang":"en","type":"review","venue":"Future Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"DNA methylation; Epigenome; Epigenetics; Reprogramming; Epigenomics; Biology; Cancer research; Gene silencing; Cancer epigenetics; Genetics; Gene; Gene expression","authors":[{"name":"Moshe Szyf","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04446095228224609,"gpt":0.3873035522682998,"spread":0.3428425999860537,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000262161,0.0002526187,0.0007544249,0.0001113994,0.00004813198,0.00000632667,0.0002600657,0.0009523859,0.00005590434],"category_scores_gemma":[0.00002873366,0.000214103,0.000351708,0.0001721892,0.00006149476,0.000001716889,0.0000720562,0.0001803246,0.00001989889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006014788,"about_ca_system_score_gemma":0.0004197229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001782177,"about_ca_topic_score_gemma":0.00003312488,"domain_scores_codex":[0.9985492,0.0002680787,0.000544397,0.0003702151,0.00008180931,0.0001862775],"domain_scores_gemma":[0.998713,0.00005399953,0.0005384629,0.0005200323,0.000116324,0.00005816609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005156647,0.00005827565,0.00000338915,0.0003929562,0.0001184188,1.909451e-7,0.00001183362,0.00000202811,0.00269111,0.000705241,0.000290103,0.9957213],"study_design_scores_gemma":[0.0001372431,0.0002649442,0.00005804621,0.00009016505,0.0003580828,0.000006888677,0.000007040062,4.566297e-7,0.0006575739,0.0001870901,0.998042,0.000190425],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002813288,0.9920991,0.0008762901,0.0001745059,0.0003834283,0.0004425767,0.00006005447,0.000009218433,0.00592667],"genre_scores_gemma":[0.0001906426,0.9950978,0.00112183,0.0000592077,0.002002817,0.00009818106,0.001032173,0.00004479887,0.0003525753],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.997752,"threshold_uncertainty_score":0.8730866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3209015618","doi":"10.2217/fon-2021-1110","title":"The role of Globo H and SSEA-4 in the Development and Progression of Cancer, and their Potential as Therapeutic Targets","year":2021,"lang":"en","type":"review","venue":"Future Oncology","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Office of the Chief Medical Examiner","funders":"","keywords":"Glycosylation; Carcinogenesis; Cell biology; Cancer cell; Ceramide; Glycan; Cancer; Embryonic stem cell; Galectin; Cell; Biology; Biochemistry; Glycoprotein; Apoptosis; Gene; Genetics","authors":[{"name":"Darren Sigal","is_ca":false},{"name":"David J. Hermel","is_ca":false},{"name":"Pei Hsu","is_ca":false},{"name":"Tillman Pearce","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01578068486255948,"gpt":0.3689534633889522,"spread":0.3531727785263928,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004115538,0.0001566501,0.0004334956,0.00003655919,0.0000769388,0.00001476903,0.0001587433,0.0003214116,0.000007516306],"category_scores_gemma":[0.00002491815,0.00007505001,0.00005198595,0.00009425379,0.0001756308,0.000001542525,0.0001804034,0.0001959259,1.748113e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001523518,"about_ca_system_score_gemma":0.0005635352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001701465,"about_ca_topic_score_gemma":0.0003337377,"domain_scores_codex":[0.9988862,0.0003393623,0.0002748215,0.0002352371,0.0001053861,0.000159002],"domain_scores_gemma":[0.9994944,0.00005503446,0.0001742896,0.0001713918,0.00007097092,0.00003389168],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003878444,0.00003730736,0.00004594711,0.0005039721,0.00008732774,0.000002757048,0.0002785797,6.775122e-8,0.0008000942,0.0001755653,0.00003529048,0.9979943],"study_design_scores_gemma":[0.0002330068,0.0002324951,0.0001567326,0.0003049035,0.00003166413,0.00005255642,0.0006978437,0.000002138862,0.001360755,0.00005150916,0.9967997,0.00007671321],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005950798,0.9929051,0.000003283919,0.0002498741,0.00007062712,0.0005471705,0.00001158097,0.00000101222,0.0002605184],"genre_scores_gemma":[0.01034466,0.9891314,0.0001037059,0.00003136791,0.0001253986,0.0001329973,0.00006136313,0.0000103144,0.00005882916],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9979176,"threshold_uncertainty_score":0.3060451,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394942521","doi":"10.2217/fon-2023-0679","title":"Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Disease; Clinical trial; Hypoxia-inducible factors; Renal cell carcinoma; Von Hippel–Lindau disease; Bioinformatics; Cancer research; Oncology; Internal medicine; Gene; Biology","authors":[{"name":"Lauren Curry","is_ca":true},{"name":"Maryam Soleimani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02583162313801747,"gpt":0.3430211738917799,"spread":0.3171895507537625,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002364988,0.0003447823,0.0007918489,0.00005977547,0.00007286399,0.00001760367,0.0003115362,0.0004355507,0.00001182044],"category_scores_gemma":[0.000006428185,0.0002118046,0.0004780203,0.0001102356,0.0001448911,0.0000015329,0.0002294119,0.0002082201,0.000004240104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003253796,"about_ca_system_score_gemma":0.0003640332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002451262,"about_ca_topic_score_gemma":0.00002335093,"domain_scores_codex":[0.9986936,0.0000541614,0.0003559578,0.0005249264,0.0001005161,0.0002708063],"domain_scores_gemma":[0.9991168,0.00004261715,0.0002055237,0.0004899082,0.0000488877,0.00009628606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009659342,0.00007328842,1.552027e-7,0.0103301,0.001478165,0.000002608688,0.00003609419,2.328906e-7,0.00006119916,0.00482417,0.009124117,0.9739733],"study_design_scores_gemma":[0.0004928428,0.0002021401,0.000007992118,0.0004757968,0.006987286,0.00002793062,0.00007995142,0.000002969141,0.000005862544,0.0001470348,0.9913518,0.0002183775],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000006463988,0.9919273,0.0003568002,0.0005145412,0.004707942,0.001438811,0.0004714646,0.000008730801,0.0005679027],"genre_scores_gemma":[0.00001720836,0.9900168,0.000399083,0.0003757804,0.005818228,0.0005899478,0.0003289538,0.00006069661,0.002393335],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9822277,"threshold_uncertainty_score":0.8637142,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3195219055","doi":"10.2217/fon-2021-0598","title":"Clinical Activity and Safety of the Anti-PD-1 Monoclonal Antibody Dostarlimab for Patients with Recurrent or Advanced dMMR Endometrial Cancer","year":2021,"lang":"en","type":"letter","venue":"Future Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Endometrial cancer; Internal medicine; Regimen; Oncology; Microsatellite instability; Clinical trial; Cancer; DNA mismatch repair; Colorectal cancer","authors":[{"name":"Ana Oaknin","is_ca":false},{"name":"Anna V. Tinker","is_ca":false},{"name":"Lucy Gilbert","is_ca":true},{"name":"Vanessa Samouëlian","is_ca":true},{"name":"Cara Mathews","is_ca":false},{"name":"Jubilee Brown","is_ca":false},{"name":"Maria-Pilar Barretina-Ginesta","is_ca":false},{"name":"Víctor Moreno","is_ca":false},{"name":"Adriano Gravina","is_ca":false},{"name":"Cyril Abdeddaim","is_ca":false},{"name":"Susana Banerjee","is_ca":false},{"name":"Wei Guo","is_ca":false},{"name":"Hadi Danaee","is_ca":false},{"name":"Ellie Im","is_ca":false},{"name":"Renaud Sabatier","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03426658383925036,"gpt":0.3826646853782454,"spread":0.3483981015389951,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003068061,0.0004550722,0.00204376,0.0001579106,0.0001215213,0.00001102449,0.0002071554,0.001155421,0.0003758029],"category_scores_gemma":[0.000663431,0.0002317685,0.000461708,0.0006373246,0.0002836467,0.0000559271,0.0001700863,0.001615325,0.000001011503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004486345,"about_ca_system_score_gemma":0.001405339,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007046356,"about_ca_topic_score_gemma":0.0001971398,"domain_scores_codex":[0.9969544,0.000476842,0.0007259301,0.0008111774,0.000550388,0.0004812962],"domain_scores_gemma":[0.9961227,0.001983647,0.0007982308,0.0004831216,0.0004715879,0.0001407011],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1398218,0.003325699,0.1508655,0.001753962,0.003384616,0.0002879725,0.0000955588,0.000001086329,0.0001254545,0.00001242579,0.1207351,0.5795909],"study_design_scores_gemma":[0.0431709,0.008214966,0.1695774,0.0003883168,0.001348424,0.00001902712,0.00001697366,0.000002017385,0.00007086073,0.000008967295,0.7769375,0.0002446417],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.5653217,0.00619318,0.00007076461,0.3932973,0.02140319,0.007865027,0.005069523,0.00005310878,0.0007262299],"genre_scores_gemma":[0.2609071,0.05021228,0.0135834,0.5219901,0.1298671,0.003129622,0.01332149,0.0007619886,0.006226983],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.6562024,"threshold_uncertainty_score":0.9451244,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127753540","doi":"10.2217/14796694.2.1.15","title":"Dexrazoxane Use In the Prevention of Anthracycline Extravasation Injury","year":2006,"lang":"en","type":"review","venue":"Future Oncology","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"","keywords":"Dexrazoxane; Anthracycline; Medicine; Cardiotoxicity; Extravasation; Doxorubicin; Epirubicin; Daunorubicin; Idarubicin; Pharmacology; Chemotherapy; Internal medicine; Pathology; Cancer; Cyclophosphamide; Breast cancer","authors":[{"name":"Brian B. Hasinoff","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06209249161300837,"gpt":0.4201365793525218,"spread":0.3580440877395134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007519569,0.0003203262,0.001755564,0.0003280824,0.00002842099,0.000007369826,0.0002093143,0.00129985,0.0001781297],"category_scores_gemma":[0.0001286357,0.0002059941,0.0004239269,0.0006156974,0.0001129553,0.00006436519,0.00002740299,0.001039472,0.00001849094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003748241,"about_ca_system_score_gemma":0.0005247962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007967713,"about_ca_topic_score_gemma":0.0004085089,"domain_scores_codex":[0.9974667,0.0006526587,0.00104087,0.0003507953,0.0002550124,0.0002338966],"domain_scores_gemma":[0.9980872,0.0004462305,0.0007942296,0.0005610243,0.00007418524,0.00003715981],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001128977,0.0008771099,0.00004537543,0.003533795,0.0001233386,0.00006855903,0.0001186904,3.743072e-7,0.00005487569,0.0001431965,0.007177082,0.9877447],"study_design_scores_gemma":[0.0009063615,0.0006490877,0.0006393199,0.003599663,0.0009955799,0.0003087762,0.00002526193,0.00000203383,0.00002762746,0.00006826833,0.9926289,0.0001491387],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001167841,0.994252,0.000063004,0.0005427388,0.0005152622,0.001884515,0.00003562529,0.00003110581,0.001507971],"genre_scores_gemma":[0.0002539801,0.9957844,0.001064823,0.0001912385,0.001248898,0.00008195233,0.0006620288,0.00004933577,0.0006633684],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9875956,"threshold_uncertainty_score":0.9999967,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3159545343","doi":"10.2217/fon-2021-0153","title":"Real-World Genetic Testing Patterns in Metastatic Castration-Resistant Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Merck Sharp and Dohme","keywords":"Medicine; FANCA; PALB2; Prostate cancer; Oncology; Genetic testing; Internal medicine; Cancer; DNA repair; Gene; Mutation; Fanconi anemia; Genetics; Germline mutation","authors":[{"name":"Neal D. Shore","is_ca":false},{"name":"Raluca Ionescu‐Ittu","is_ca":true},{"name":"Lingfeng Yang","is_ca":false},{"name":"François Laliberté","is_ca":true},{"name":"Malena Mahendran","is_ca":true},{"name":"Dominique Lejeune","is_ca":true},{"name":"Louise Yu","is_ca":false},{"name":"Joseph E. Burgents","is_ca":false},{"name":"Mei Sheng Duh","is_ca":false},{"name":"Sameer R. Ghate","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0559407481845942,"gpt":0.3889786225716865,"spread":0.3330378743870923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001639466,0.0001463909,0.0003597587,0.0001508071,0.00006332335,0.00001806499,0.00005323199,0.00006449658,0.0005201426],"category_scores_gemma":[0.00006143994,0.0001153387,0.00004647977,0.0005954258,0.00004869247,0.00004047056,0.00003896688,0.000296703,0.00001676874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006490545,"about_ca_system_score_gemma":0.001906773,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001426575,"about_ca_topic_score_gemma":0.02863272,"domain_scores_codex":[0.9985793,0.0001703539,0.0003028038,0.0003418476,0.0002032316,0.0004024365],"domain_scores_gemma":[0.9992183,0.0001586523,0.00007668923,0.000204303,0.0002054947,0.000136533],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001361407,0.0008426367,0.7506262,0.0007646057,0.000306228,0.03004169,0.002507759,0.00009922433,0.059344,0.0002734513,0.002400525,0.1514322],"study_design_scores_gemma":[0.004233366,0.0005401294,0.9706986,0.0002351288,0.0001405161,0.0001508881,0.001248723,0.0001562594,0.00400689,0.0001523456,0.01827739,0.0001598035],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9802477,0.002856715,0.000005747272,0.007832441,0.0004224674,0.0006193665,0.00006814305,0.00003780513,0.007909553],"genre_scores_gemma":[0.9807584,0.002425174,0.005849065,0.0005777416,0.0007551099,0.0004172436,0.0001622036,0.00003893109,0.009016085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2200723,"threshold_uncertainty_score":0.9890922,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4323294773","doi":"10.2217/fon-2022-1059","title":"TRUST-II: a global phase II study of taletrectinib in <i>ROS1</i> -positive non-small-cell lung cancer and other solid tumors","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Crizotinib; ROS1; Medicine; Lung cancer; Internal medicine; Oncology; Cancer; Brain metastasis; Clinical trial; Interim analysis; Clinical endpoint; Adverse effect; Adenocarcinoma; Metastasis","authors":[{"name":"Misako Nagasaka","is_ca":false},{"name":"Yuichiro Ohe","is_ca":false},{"name":"Caicun Zhou","is_ca":false},{"name":"Chang‐Min Choi","is_ca":false},{"name":"Nong Yang","is_ca":false},{"name":"Geoffrey Liu","is_ca":true},{"name":"Enriqueta Felip","is_ca":false},{"name":"M. Pérol","is_ca":false},{"name":"Benjamin Besse","is_ca":false},{"name":"Jorgé Nieva","is_ca":false},{"name":"Luis E. Raez","is_ca":false},{"name":"Nathan A. Pennell","is_ca":false},{"name":"Anastasios Dimou","is_ca":false},{"name":"Filippo de Marinis","is_ca":false},{"name":"Fortunato Ciardiello","is_ca":false},{"name":"Takashi Seto","is_ca":false},{"name":"Zheyi Hu","is_ca":false},{"name":"Max Yu-Chen Pan","is_ca":false},{"name":"Weiqing Wang","is_ca":false},{"name":"Shuanglian Li","is_ca":false},{"name":"Sai‐Hong Ignatius Ou","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01232102561456113,"gpt":0.3856566028457878,"spread":0.3733355772312267,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009036444,0.0001585293,0.0004584593,0.0001121489,0.0001152384,0.000004043103,0.0000536164,0.0001149144,0.00008859535],"category_scores_gemma":[0.000009471501,0.0001281423,0.00004394662,0.0005052108,0.00005233266,0.00002985416,0.00007582227,0.000144411,0.000003436623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003687603,"about_ca_system_score_gemma":0.0004005254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001495835,"about_ca_topic_score_gemma":0.00412924,"domain_scores_codex":[0.9990245,0.0000454037,0.0002641527,0.000300058,0.0001086827,0.0002571683],"domain_scores_gemma":[0.9995396,0.00003732316,0.0001206128,0.0001439854,0.00006185094,0.00009658729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003814512,0.02421475,0.7433549,0.0004183714,0.001728231,0.002197044,0.1244693,0.000133739,0.005982711,0.0001902795,0.02519696,0.06829922],"study_design_scores_gemma":[0.1657129,0.0747557,0.5623519,0.0006617812,0.004105554,0.0003019623,0.0921715,0.001209598,0.003789404,0.00008254082,0.09392966,0.0009274471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9856531,0.0006182887,0.000002605959,0.001403869,0.0004937877,0.001223444,0.0001923472,0.00003779748,0.01037475],"genre_scores_gemma":[0.9969651,0.00007608483,0.00009014524,0.0007102417,0.0003652173,0.0002846941,0.00003039988,0.00001984728,0.001458261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1810029,"threshold_uncertainty_score":0.5225491,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4224311311","doi":"10.2217/fon-2022-0045","title":"A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ <i>PIK3CA</i> -mutated breast cancer","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Trastuzumab; Medicine; Fulvestrant; Oncology; Internal medicine; Breast cancer; Chemotherapy; Cancer; Estrogen receptor","authors":[{"name":"José Alejandro Pérez Fidalgo","is_ca":false},{"name":"Carmen Criscitiello","is_ca":false},{"name":"Eva Carrasco","is_ca":false},{"name":"Meredith M. Regan","is_ca":false},{"name":"Angelo Di Leo","is_ca":false},{"name":"Karin Ribi","is_ca":false},{"name":"Virginie Adam","is_ca":false},{"name":"Philippe L. Bédard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03373686270539864,"gpt":0.405549785522902,"spread":0.3718129228175033,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001114618,0.0003542718,0.001236585,0.0004070307,0.000134565,0.00001099496,0.0004345187,0.0003133678,0.006510433],"category_scores_gemma":[0.00004419947,0.0003340945,0.0002591615,0.001219865,0.0002618096,0.00007151088,0.000104724,0.001476748,0.000009070069],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003016694,"about_ca_system_score_gemma":0.004180958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001720948,"about_ca_topic_score_gemma":0.001310666,"domain_scores_codex":[0.9959822,0.0006186001,0.0009065102,0.0006888474,0.0009631859,0.000840676],"domain_scores_gemma":[0.9984881,0.0002338781,0.0002784229,0.0005369681,0.0001663309,0.0002963101],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6796848,0.01260008,0.0001594419,0.0001635416,0.0004214453,0.001027281,0.004539615,0.0001150018,0.01332763,0.0001152967,0.02360034,0.2642455],"study_design_scores_gemma":[0.7063742,0.03040134,0.0009478512,0.00007256244,0.0001685039,0.0005405919,0.004477333,0.0004435542,0.001575093,0.00002515554,0.2545993,0.0003745366],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9676818,0.001142493,0.00001953552,0.01931926,0.003648501,0.002660631,0.0005486474,0.00008768219,0.004891395],"genre_scores_gemma":[0.9940339,0.0008403607,0.0001803063,0.001114723,0.002113022,0.00106612,0.0001441533,0.00009417443,0.0004132557],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.263871,"threshold_uncertainty_score":0.9999111,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3207977249","doi":"10.2217/fon-2021-0753","title":"Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Placebo; Randomized controlled trial; Cancer; Pathology","authors":[{"name":"Ciara C. O’Sullivan","is_ca":false},{"name":"Karla V. Ballman","is_ca":false},{"name":"Linda McCall","is_ca":false},{"name":"Anuhya Kommalapati","is_ca":false},{"name":"Tyler Zemla","is_ca":false},{"name":"Anna Weiss","is_ca":false},{"name":"Melissa P. Mitchell","is_ca":false},{"name":"Victoria Blinder","is_ca":false},{"name":"Nadine Tung","is_ca":false},{"name":"William Irvin","is_ca":false},{"name":"Myoung-Hee Lee","is_ca":false},{"name":"Matthew P. Goetz","is_ca":false},{"name":"W. Fraser Symmans","is_ca":false},{"name":"Virginia F. Borges","is_ca":false},{"name":"Ian E. Krop","is_ca":false},{"name":"Lisa A. Carey","is_ca":false},{"name":"Ann H. Partridge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01568102170165933,"gpt":0.3375341293603767,"spread":0.3218531076587174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003961391,0.0003708563,0.0008729729,0.0001436392,0.0001073083,0.00002994226,0.0002772507,0.0004261291,0.002357787],"category_scores_gemma":[0.0001818849,0.0003087424,0.00007709822,0.0007468939,0.0002724701,0.0001193138,0.0001803496,0.001245819,0.0001470267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001977684,"about_ca_system_score_gemma":0.00500587,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008689594,"about_ca_topic_score_gemma":0.01489098,"domain_scores_codex":[0.9963145,0.0006394681,0.0004947261,0.0008863491,0.0007588301,0.0009061038],"domain_scores_gemma":[0.9973831,0.0004071369,0.0001929268,0.000608436,0.001020075,0.0003883843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01025919,0.002469817,0.8467549,0.0003666962,0.0004040753,0.003564176,0.002863178,0.00003807422,0.001006007,0.0002004774,0.08439041,0.04768297],"study_design_scores_gemma":[0.01007076,0.001866575,0.9242729,0.000782846,0.00008981108,0.000303149,0.001319563,0.00000721762,0.001663201,0.00002130702,0.05924932,0.0003533717],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9111881,0.00193061,0.000007266065,0.07021521,0.001199087,0.001741974,0.0004743284,0.00007339235,0.01317007],"genre_scores_gemma":[0.9823472,0.001014159,0.002266835,0.007310797,0.002686844,0.0006552591,0.0005041093,0.0001502564,0.00306455],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07751795,"threshold_uncertainty_score":0.9999365,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2162077153","doi":"10.2217/fon.15.153","title":"Rapid Access Palliative Radiation Therapy Programs: An Efficient Model of Care","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Multidisciplinary approach; Palliative care; Narrative review; Radiation therapy; Radiation oncology; Medical physics; Intensive care medicine; Nursing; Internal medicine","authors":[{"name":"Kristopher Dennis","is_ca":true},{"name":"Kelly Linden","is_ca":true},{"name":"Tracy A. Balboni","is_ca":false},{"name":"Edward Chow","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1773303789361742,"gpt":0.4611510236039245,"spread":0.2838206446677503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005118022,0.0004407597,0.002462639,0.0003188872,0.00003479669,0.00001970781,0.0004106561,0.000465266,0.0001112866],"category_scores_gemma":[0.000052974,0.0003137877,0.0004264811,0.0003682946,0.00009753936,0.00006182073,0.00009877082,0.0003809186,0.00001693459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005502342,"about_ca_system_score_gemma":0.002107805,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000705359,"about_ca_topic_score_gemma":0.000006750998,"domain_scores_codex":[0.9973663,0.0005201882,0.0007280157,0.0005409719,0.0005380142,0.0003065243],"domain_scores_gemma":[0.9976308,0.00004628304,0.0008883406,0.0006897598,0.000446679,0.0002980905],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002430875,0.0009380589,0.000007466627,0.01680027,0.0004077315,0.00002894094,0.001267384,0.00004151282,6.397711e-8,0.0002998174,0.001660389,0.9783053],"study_design_scores_gemma":[0.002303201,0.002128313,0.00001820442,0.001701569,0.002373497,0.00000392792,0.0007239794,0.0008621629,3.119038e-7,0.0000295726,0.9896125,0.0002427761],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005809601,0.9899918,0.0001368181,0.0002062727,0.0005805556,0.004530762,0.0001059217,0.00006738189,0.004322332],"genre_scores_gemma":[0.00006718,0.9941581,0.001774176,0.0002555278,0.0007062537,0.0005750433,0.00227252,0.00007160269,0.0001195603],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9879521,"threshold_uncertainty_score":0.9999314,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3133493210","doi":"10.2217/fon-2020-1274","title":"Molecular and Morphological Changes Induced by Ivosidenib Correlate with Efficacy in Mutant- <i>IDH1</i> Cholangiocarcinoma","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Trinity College","funders":"Agios Pharmaceuticals","keywords":"IDH1; Isocitrate dehydrogenase; Medicine; Cancer research; Intrahepatic Cholangiocarcinoma; Downregulation and upregulation; Mutant; Internal medicine; Oncology; Biology; Gene; Enzyme; Genetics","authors":[{"name":"Elia Aguado-Fraile","is_ca":false},{"name":"Anna M. Tassinari","is_ca":false},{"name":"Yuko Ishii","is_ca":false},{"name":"Carlie Sigel","is_ca":false},{"name":"Maeve A. Lowery","is_ca":true},{"name":"Lipika Goyal","is_ca":false},{"name":"Camelia Gliser","is_ca":false},{"name":"Liewen Jiang","is_ca":false},{"name":"Shuchi S. Pandya","is_ca":false},{"name":"Bin Wu","is_ca":false},{"name":"Nabeel Bardeesy","is_ca":false},{"name":"Sung Choe","is_ca":false},{"name":"Vikram Deshpande","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01478920642627858,"gpt":0.2702181729730269,"spread":0.2554289665467483,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001114401,0.0002588691,0.0006470482,0.00009677939,0.0000649279,0.00001736891,0.000077789,0.0003371854,0.00007370312],"category_scores_gemma":[0.00005221866,0.0001972283,0.0000617372,0.0003618861,0.0001236738,0.00003709472,0.0001171502,0.0005726221,0.00001147548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001357437,"about_ca_system_score_gemma":0.0001737454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005709658,"about_ca_topic_score_gemma":0.0004553935,"domain_scores_codex":[0.9985026,0.0001209452,0.0002089823,0.0005578569,0.0001933011,0.0004163523],"domain_scores_gemma":[0.9992787,0.00009860549,0.00007528012,0.0002789981,0.00009286409,0.0001755859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.001885091,0.001235858,0.1239881,0.0001381083,0.0004684309,0.03913347,0.002985081,0.00000197578,0.7944957,0.0004051476,0.01007779,0.0251852],"study_design_scores_gemma":[0.01600138,0.004124451,0.8501033,0.0001685318,0.0004214538,0.008219446,0.002441994,0.00001222504,0.04436689,0.00003448976,0.07352575,0.0005800976],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9623083,0.01283937,0.00000735564,0.02001552,0.0002866399,0.0003385843,0.00001136343,0.00005290831,0.004139899],"genre_scores_gemma":[0.9930595,0.0005093362,0.0002488454,0.005568841,0.0003255523,0.00006110774,0.00005993805,0.00003067954,0.0001361699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7501288,"threshold_uncertainty_score":0.8042737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013307793","doi":"10.2217/14796694.2.5.627","title":"Tumor Dormancy and the Role of Metastasis Suppressor Genes In Regulating Ectopic Growth","year":2006,"lang":"en","type":"review","venue":"Future Oncology","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Metastasis; Ectopic expression; Metastasis suppressor; Suppressor; Dormancy; Metastasis Suppressor Gene; Cancer research; Medicine; Malignancy; Gene; Primary tumor; Cancer; Biology; Oncology; Internal medicine; Genetics; Botany","authors":[{"name":"Benjamin D. Hedley","is_ca":true},{"name":"Alison L. Allan","is_ca":true},{"name":"Ann F. Chambers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01169550857596107,"gpt":0.2927156381989339,"spread":0.2810201296229728,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005705583,0.0003519238,0.00155278,0.0001357526,0.00004783408,0.00001180315,0.0004012878,0.0004188151,0.00002734692],"category_scores_gemma":[0.00007765736,0.0002296921,0.0003216994,0.0001860858,0.0001790606,0.000003444775,0.0002639299,0.0002574758,0.000001687074],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003753832,"about_ca_system_score_gemma":0.0002696127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008980921,"about_ca_topic_score_gemma":0.0002517148,"domain_scores_codex":[0.9977604,0.0006493372,0.0006828785,0.0004757325,0.0001366465,0.0002950562],"domain_scores_gemma":[0.9987088,0.0001020376,0.000604585,0.0004695725,0.00006921926,0.00004572573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007675641,0.00004304893,0.00001219477,0.002301508,0.0002145412,0.000008127417,0.00002363906,9.105202e-7,0.0007011303,0.003145404,0.000413979,0.9930587],"study_design_scores_gemma":[0.0009190853,0.0001616989,0.00001203155,0.0002939402,0.000527507,0.0001067004,0.00004886698,0.000001833535,0.003880877,0.0005250507,0.9933105,0.0002119586],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004800377,0.9967188,0.00002085116,0.00009752535,0.0002880167,0.000645647,0.00008861031,0.000005994867,0.001654473],"genre_scores_gemma":[0.0005111053,0.995594,0.002344288,0.00006541405,0.0009487113,0.0002313828,0.000169336,0.00004654247,0.00008923021],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9928965,"threshold_uncertainty_score":0.9366571,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2000905384","doi":"10.2217/14796694.4.6.779","title":"The Future in Psychosocial Oncology: Screening for Emotional Distress – The Sixth Vital Sign","year":2008,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Alberta Heritage Foundation for Medical Research; Australian Government","keywords":"Biopsychosocial model; Psychosocial; Medicine; Survivorship curve; Distress; Healthcare system; Health care; Sign (mathematics); Pediatric oncology; Population; Intensive care medicine; Oncology; Psychiatry; Internal medicine; Clinical psychology; Cancer; Environmental health","authors":[{"name":"Bejoy C. Thomas","is_ca":true},{"name":"Barry D. Bultz","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04200507105926059,"gpt":0.3883318825882691,"spread":0.3463268115290085,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005760952,0.0005466979,0.001991622,0.0001242178,0.0005968733,0.00003057336,0.0005905239,0.001661338,0.00009343736],"category_scores_gemma":[0.000089544,0.0002892883,0.001091207,0.000479597,0.0003743096,0.0000390701,0.0001050605,0.00189094,0.00002031779],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001011367,"about_ca_system_score_gemma":0.002023213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004892947,"about_ca_topic_score_gemma":0.008657132,"domain_scores_codex":[0.996878,0.0007018258,0.0007657119,0.0006124365,0.0003759796,0.0006659973],"domain_scores_gemma":[0.9970649,0.001569872,0.0005152409,0.0005266065,0.0001702625,0.000153094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003557996,0.0001345482,0.00001706464,0.001011957,0.0002389745,0.0001042519,0.0006157907,2.165849e-7,1.080697e-7,0.001121682,0.1003409,0.8960587],"study_design_scores_gemma":[0.001428706,0.0007971578,0.0002020707,0.001170914,0.0004992394,0.000717079,0.002022984,0.000001338283,5.966895e-8,0.00008542559,0.9927924,0.0002826494],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008943519,0.9629282,0.0001085577,0.01794286,0.01070879,0.002408951,0.0004074905,0.00004829364,0.005437884],"genre_scores_gemma":[0.0000324074,0.9609646,0.0001884886,0.001139742,0.03433113,0.001162117,0.000982692,0.0000848826,0.00111394],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8957761,"threshold_uncertainty_score":0.999956,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132123971","doi":"10.2217/fon.09.65","title":"Physical Activity, Obesity and Risk for Esophageal Adenocarcinoma","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal University Hospital","funders":"Nova Scotia Health Research Foundation; Saskatchewan Health Research Foundation","keywords":"Medicine; Esophageal adenocarcinoma; Obesity; Physical activity; Esophageal cancer; Internal medicine; Adenocarcinoma; Oncology; Cancer; Physical therapy","authors":[{"name":"Lloyd Balbuena","is_ca":true},{"name":"Alan G. Casson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04542401441194394,"gpt":0.4123853684843281,"spread":0.3669613540723842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001978124,0.0004555912,0.002535647,0.0001514081,0.0001489448,0.00001778496,0.0001351647,0.0006007008,0.00003436982],"category_scores_gemma":[0.0000595586,0.0003133198,0.0005983182,0.0001620465,0.0001185157,0.00004200565,0.00009139237,0.0009661463,0.00004596322],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006849602,"about_ca_system_score_gemma":0.001039385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003719327,"about_ca_topic_score_gemma":0.00004761295,"domain_scores_codex":[0.9981111,0.0002736323,0.0002064363,0.0006570847,0.0002297167,0.0005220446],"domain_scores_gemma":[0.9984823,0.0004225601,0.0002361568,0.0003835009,0.00007007492,0.0004053569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002645965,0.0008594777,0.0002988827,0.006166134,0.0004909089,0.0006403091,0.00004357075,8.283333e-9,6.336078e-8,0.000262943,0.003007638,0.9879655],"study_design_scores_gemma":[0.00228212,0.007012637,0.006430185,0.0007272591,0.003937971,0.000570926,0.000007314426,0.000004059709,0.000003335033,0.0002031684,0.9786149,0.0002061376],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007055881,0.9948615,0.00001292447,0.0003823164,0.0002331237,0.002757385,0.000234965,0.00005393162,0.0007582037],"genre_scores_gemma":[0.0007579738,0.9922037,0.0005099358,0.00006518539,0.004961113,0.0004498768,0.0001732418,0.00005034191,0.0008286957],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9877594,"threshold_uncertainty_score":0.9999319,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138828358","doi":"10.2217/fon.09.119","title":"Nimotuzumab in Pediatric Glioma","year":2009,"lang":"en","type":"review","venue":"Future Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nimotuzumab; Medicine; Context (archaeology); Glioma; Monoclonal antibody; Epidermal growth factor receptor; In vivo; Oncology; Cancer research; Pharmacology; Internal medicine; Immunology; Receptor; Antibody; Biology","authors":[{"name":"Catherine G. Lam","is_ca":true},{"name":"Éric Bouffet","is_ca":true},{"name":"Ute Bartels","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03178295124147681,"gpt":0.3674432645124994,"spread":0.3356603132710226,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001560024,0.0004703131,0.002877462,0.0008525202,0.00003072204,0.000009602446,0.000157894,0.001139453,0.0002471193],"category_scores_gemma":[0.00004054366,0.0003265226,0.0005702275,0.000916734,0.00002318778,0.00002267859,0.00004681743,0.0006515498,0.0004774867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001050112,"about_ca_system_score_gemma":0.0009937547,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009125846,"about_ca_topic_score_gemma":0.00006022754,"domain_scores_codex":[0.9980016,0.0001742084,0.0006609205,0.0005364009,0.0001877841,0.0004390313],"domain_scores_gemma":[0.998858,0.0001690632,0.0002944456,0.000450023,0.0000418476,0.0001866385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001688825,0.000974118,0.0001170364,0.003607096,0.00008713244,0.005711505,0.00002210537,3.228917e-8,8.369304e-8,0.0002465608,0.0167733,0.9724441],"study_design_scores_gemma":[0.0018582,0.001066695,0.0008379912,0.001496044,0.002458529,0.001308524,0.000009320405,1.418324e-7,3.175296e-7,0.00003055054,0.990707,0.0002266941],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001418245,0.9854043,1.552817e-7,0.000999853,0.00093094,0.001173572,0.00001503426,0.00005482942,0.01127951],"genre_scores_gemma":[0.00004099573,0.9946561,0.000227012,0.0002348117,0.004169243,0.0002627406,0.0002488102,0.00004953412,0.0001107079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9739337,"threshold_uncertainty_score":0.9999187,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2011966810","doi":"10.2217/14796694.3.5.539","title":"Targeting the Rna-Binding Protein Sam68 As A Treatment For Cancer?","year":2007,"lang":"en","type":"review","venue":"Future Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Suppressor; RNA-binding protein; Oncogene; RNA; Biology; Carcinogenesis; Cancer research; Cancer; Breast cancer; Mammary tumor; Haploinsufficiency; Cell biology; Genetics; Gene; Phenotype","authors":[{"name":"Kiven Erique Lukong","is_ca":true},{"name":"Stéphane Richard","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05321973433173025,"gpt":0.4203583919596777,"spread":0.3671386576279474,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007268958,0.0003914476,0.0008590763,0.00008087662,0.0002944639,0.00003165626,0.000424061,0.0008042551,0.00004572498],"category_scores_gemma":[0.000156889,0.0002244269,0.0005005094,0.0001394424,0.00007875642,0.000001799565,0.0001202483,0.0003238312,0.00002688378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004063563,"about_ca_system_score_gemma":0.001361499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000917813,"about_ca_topic_score_gemma":0.000266397,"domain_scores_codex":[0.9979634,0.0002730445,0.0004037789,0.0005487921,0.0001340006,0.0006770091],"domain_scores_gemma":[0.9989792,0.0001236972,0.0002999071,0.0003780312,0.0000862916,0.0001328401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008468241,0.00004716494,5.25157e-7,0.00101149,0.0003114418,0.00001967707,0.00002081405,6.560483e-7,0.009153759,0.000128857,0.004438709,0.9847822],"study_design_scores_gemma":[0.0004279692,0.001239336,7.586839e-8,0.0005080843,0.0001752981,0.00004300334,0.000102124,0.000002593878,0.00121568,0.000006845269,0.9960435,0.0002354862],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005289881,0.994003,0.0001307273,0.0004730331,0.000541962,0.002919645,0.00009673699,0.00001346614,0.001292447],"genre_scores_gemma":[0.000008826874,0.9763903,0.000660206,0.0001244523,0.005601699,0.002401798,0.0005400649,0.00006978554,0.01420285],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9916048,"threshold_uncertainty_score":0.9151862,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402838411","doi":"10.1080/14796694.2024.2390821","title":"Barriers and facilitators to next-generation sequencing use in United States oncology settings: a systematic review","year":2024,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Bayer HealthCare","keywords":"Medicine; Radiation oncology; Oncology; MEDLINE; Family medicine; Medical education; Internal medicine; Radiation therapy","authors":[{"name":"Andrea Ferreira‐Gonzalez","is_ca":false},{"name":"Gilbert Ko","is_ca":false},{"name":"Nicole Fusco","is_ca":false},{"name":"Fiona Stewart","is_ca":false},{"name":"Kristin D. Kistler","is_ca":false},{"name":"Sreevalsa Appukkuttan","is_ca":false},{"name":"Brian Hocum","is_ca":false},{"name":"Stefan Allen","is_ca":false},{"name":"Svetlana Babajanyan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04744542064128006,"gpt":0.3367015373601753,"spread":0.2892561167188953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007995054,0.000503765,0.002106896,0.0003536179,0.00006177239,0.00007991419,0.0002427644,0.0008404622,0.00001279422],"category_scores_gemma":[0.001242573,0.0004107844,0.0002345625,0.0004971588,0.00006533354,0.000006588189,0.0002577101,0.000441487,0.00003128887],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008866867,"about_ca_system_score_gemma":0.001567984,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001060567,"about_ca_topic_score_gemma":0.001381767,"domain_scores_codex":[0.9969886,0.0006816197,0.001033679,0.0007954483,0.0001072568,0.00039343],"domain_scores_gemma":[0.9985932,0.0002128159,0.0003358322,0.0004678353,0.0001109391,0.0002794398],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002094845,0.00002513186,0.000003139237,0.8775147,0.000488956,0.0002366556,0.0004711537,0.00003062403,0.0001921444,0.0001888961,0.06212155,0.05870613],"study_design_scores_gemma":[0.0001341953,0.0005365917,7.794292e-8,0.08062668,0.001399419,0.0001754759,0.0003520921,0.00002726981,0.000004339573,0.000007076179,0.91637,0.0003667347],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003040076,0.9952598,0.00002291125,0.0005863099,0.0009227947,0.002414386,0.0004170634,0.00001738404,0.0000553586],"genre_scores_gemma":[0.00001181059,0.9908305,0.0004531951,0.004948975,0.0006726232,0.0008179736,0.002023709,0.0000677538,0.0001734641],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8542485,"threshold_uncertainty_score":0.9998344,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163739312","doi":"10.2217/fon.14.254","title":"The Role of Oncolytic Virus Immunotherapies to Subvert Cancer Immune Evasion","year":2015,"lang":"en","type":"review","venue":"Future Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Immunotherapy; Cancer immunotherapy; Evasion (ethics); Medicine; Immune system; Virotherapy; Cancer; Cancer treatment; Cancer therapy; Immunology; Immunity; Cancer vaccine; Cancer research; Internal medicine","authors":[{"name":"Samuel T. Workenhe","is_ca":true},{"name":"Meghan L. Verschoor","is_ca":true},{"name":"Karen Mossman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02963852322677003,"gpt":0.3924585436654922,"spread":0.3628200204387221,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001070225,0.0004624855,0.00135782,0.0001281659,0.0001642084,0.00002421593,0.001192457,0.0009252129,0.0001046668],"category_scores_gemma":[0.00006794056,0.0003001553,0.0004947876,0.0003313279,0.0002067295,0.0000026649,0.0003876901,0.0004848925,0.00009201911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003751124,"about_ca_system_score_gemma":0.00297667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001492915,"about_ca_topic_score_gemma":0.001837656,"domain_scores_codex":[0.9971079,0.000750746,0.0006864232,0.0005419884,0.0003526888,0.0005602117],"domain_scores_gemma":[0.9978399,0.00009706713,0.0004196634,0.001142654,0.0003384012,0.0001623759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00141201,0.00008838261,9.713613e-7,0.000334817,0.0004928124,0.000003427594,0.00008104525,0.000002556573,0.02845596,0.00002541702,0.004301821,0.9648008],"study_design_scores_gemma":[0.0004369061,0.004464917,0.000001865748,0.0003965872,0.0001608884,0.00002284755,0.000120797,6.594241e-7,0.008189047,0.00003690581,0.9858626,0.0003059984],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005648972,0.9955345,0.000001984338,0.0002868762,0.0009618201,0.001221422,0.0001274579,0.00001301373,0.001287966],"genre_scores_gemma":[0.00006698942,0.9954194,0.00005835144,0.0001432476,0.001781128,0.0006354085,0.0001601023,0.0001108103,0.001624542],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9815608,"threshold_uncertainty_score":0.999945,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999540397","doi":"10.2217/fon.14.163","title":"On the Contribution of S100A10 and Annexin A2 to Plasminogen Activation and Oncogenesis: An Enduring Ambiguity","year":2014,"lang":"en","type":"review","venue":"Future Oncology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Carcinogenesis; Ambiguity; Annexin A2; Cancer research; Annexin; Cancer; Internal medicine; Pathology; Linguistics; Philosophy","authors":[{"name":"Moamen Bydoun","is_ca":true},{"name":"David M. Waisman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02308852363637881,"gpt":0.3250235927638751,"spread":0.3019350691274963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000428152,0.0002738388,0.0007136046,0.00007458468,0.0001124508,0.00001655759,0.0001788054,0.0006683611,0.00000974304],"category_scores_gemma":[0.0001384242,0.0001845579,0.0001067397,0.00008456854,0.00008037503,0.000003768469,0.0001366707,0.0001899657,0.000002991025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000041969,"about_ca_system_score_gemma":0.0001500409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000224195,"about_ca_topic_score_gemma":0.0001089328,"domain_scores_codex":[0.9985662,0.0003660246,0.0003126398,0.0004546613,0.00008897931,0.0002115359],"domain_scores_gemma":[0.9990923,0.00008167173,0.0002890728,0.0003487119,0.00008333218,0.0001048651],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001900801,0.0001243514,0.00001706811,0.0008949501,0.0001771806,0.000002875501,0.00007180638,0.000001462682,0.01205955,0.004336083,0.001133319,0.9809912],"study_design_scores_gemma":[0.0002769667,0.0016378,0.000114988,0.0004935949,0.000120708,0.0000291633,0.00004981063,0.000001787489,0.006138036,0.00006379717,0.9908656,0.0002077155],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.1107203,0.8859933,0.0003851307,0.000403223,0.000344805,0.001507316,0.00009593376,0.00001652052,0.0005334535],"genre_scores_gemma":[0.05699768,0.9399232,0.0001377186,0.0006039524,0.001634345,0.000217462,0.0003593331,0.0000451838,0.00008108299],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9897323,"threshold_uncertainty_score":0.7526051,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4281396346","doi":"10.2217/fon-2021-1629","title":"Targeting <i>FGFR3</i> Alterations with Adjuvant Infigratinib in Invasive Urothelial Carcinoma: the Phase III PROOF 302 Trial","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Helsinn","keywords":"Medicine; Placebo; Clinical endpoint; Tolerability; Metastatic Urothelial Carcinoma; Internal medicine; Oncology; Adjuvant; Bladder cancer; Cisplatin; Urothelial cancer; Urology; Randomized controlled trial; Adverse effect; Urothelial carcinoma; Cancer; Chemotherapy; Pathology","authors":[{"name":"Sumanta K. Pal","is_ca":false},{"name":"Diederik M. Somford","is_ca":false},{"name":"Petros Grivas","is_ca":false},{"name":"Srikala S. Sridhar","is_ca":true},{"name":"Shilpa Gupta","is_ca":false},{"name":"Joaquim Bellmunt","is_ca":false},{"name":"Guru Sonpavde","is_ca":false},{"name":"Mark T. Fleming","is_ca":false},{"name":"Seth P. Lerner","is_ca":false},{"name":"Yohann Loriot","is_ca":false},{"name":"Jean Hoffman‐Censits","is_ca":false},{"name":"Begoña P. Valderrama","is_ca":false},{"name":"Corina Andresen","is_ca":false},{"name":"Marco J. Schnabel","is_ca":false},{"name":"Suzanne Cole","is_ca":false},{"name":"Siamak Daneshmand","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01913689018658343,"gpt":0.3077494896688529,"spread":0.2886125994822695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002723247,0.0002135315,0.0004727678,0.0001052381,0.0004020238,0.00001543135,0.0001567631,0.00008825609,0.0008630967],"category_scores_gemma":[0.00004671785,0.0001329421,0.00008387653,0.0003583565,0.00009370391,0.00006202995,0.00008184727,0.0006380168,0.000008289813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003802401,"about_ca_system_score_gemma":0.001845928,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002879839,"about_ca_topic_score_gemma":0.001521402,"domain_scores_codex":[0.9982532,0.0003424708,0.0003959395,0.0003560578,0.0003065676,0.0003457995],"domain_scores_gemma":[0.999232,0.0001509612,0.0001682917,0.0002809947,0.00007086401,0.00009687667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6362478,0.01950552,0.0260243,0.0002229313,0.001193226,0.006531858,0.06946618,0.001106074,0.02376309,0.003250044,0.1590147,0.05367439],"study_design_scores_gemma":[0.4702234,0.03673089,0.001605667,0.0000323981,0.0005222005,0.0006462404,0.009059312,0.0001712437,0.002795954,0.0001370442,0.4776783,0.000397342],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9618933,0.001218694,0.00007294672,0.01790565,0.002055048,0.005736943,0.0002356693,0.00006334408,0.01081839],"genre_scores_gemma":[0.9900642,0.0000266739,0.0002550586,0.003969079,0.00252865,0.002253369,0.0002315902,0.00003387621,0.0006375278],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3186637,"threshold_uncertainty_score":0.9450304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131759521","doi":"10.2217/fon.11.134","title":"Oncolytic Viruses: Smart Therapeutics for Smart Cancers","year":2011,"lang":"en","type":"editorial","venue":"Future Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Canada","funders":"","keywords":"Oncolytic virus; Medicine; Cancer research; Cancer; Oncology; Internal medicine","authors":[{"name":"Rebecca C. Auer","is_ca":true},{"name":"John C. Bell","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0324954202615448,"gpt":0.3581239193669639,"spread":0.3256284991054191,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0008200903,0.0006689854,0.0008459663,0.0001666787,0.0002174345,0.00004147296,0.001151967,0.00387799,0.0002167869],"category_scores_gemma":[0.000197772,0.0006332148,0.0004517886,0.0001598899,0.0003063677,0.000004709016,0.0002340902,0.001086283,0.00009084377],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007209213,"about_ca_system_score_gemma":0.006604299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001649634,"about_ca_topic_score_gemma":0.009027575,"domain_scores_codex":[0.9964506,0.0003623536,0.0005498696,0.001136451,0.0004896339,0.001011104],"domain_scores_gemma":[0.9972976,0.0002753594,0.0003824262,0.001154774,0.0006440982,0.0002456724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0100822,0.0001549616,0.00001254683,0.0001112255,0.0007560005,0.00001323635,0.0001148357,0.000003176888,0.02317125,0.00001880002,0.9515583,0.01400348],"study_design_scores_gemma":[0.002613642,0.01697936,0.000003651194,0.00002675431,0.0002148623,0.000005888749,0.00008889151,0.000005703354,0.01768781,0.000109357,0.9616194,0.0006446168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.002288163,0.008495476,0.0002104594,0.0004887547,0.977102,0.001996191,0.001226013,0.00007103024,0.008121951],"genre_scores_gemma":[0.0003390959,0.006065249,0.0008146631,0.002350313,0.977949,0.001080352,0.002533461,0.0003190748,0.008548754],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.0168244,"threshold_uncertainty_score":0.9996119,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007775064","doi":"10.2217/14796694.1.4.511","title":"Notch Signaling in T-Cell Acute Lymphoblastic Leukemia","year":2005,"lang":"en","type":"review","venue":"Future Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Chromosomal translocation; Lymphoblastic Leukemia; Leukemia; Gene; Disease; Cancer research; Etiology; Immunology; T cell; Bioinformatics; Biology; Genetics; Internal medicine; Immune system","authors":[{"name":"Andrew P. Weng","is_ca":true},{"name":"Arthur Lau","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01258458081867867,"gpt":0.307365435214731,"spread":0.2947808543960523,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002089989,0.0004954091,0.001177027,0.0002112165,0.00005021357,0.00001581663,0.0003687679,0.002216051,0.00009593193],"category_scores_gemma":[0.00001963571,0.0004678426,0.0004031747,0.0003092888,0.00006216877,0.000003233174,0.0001527838,0.0004829127,0.0001274373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001315071,"about_ca_system_score_gemma":0.002347732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001157097,"about_ca_topic_score_gemma":0.0002145977,"domain_scores_codex":[0.9977083,0.0002503838,0.0006806778,0.0007538878,0.0001387637,0.0004679745],"domain_scores_gemma":[0.9988678,0.00004743758,0.0004340807,0.0004894302,0.00005637403,0.0001048413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005159042,0.00005871221,9.299541e-7,0.0009000503,0.0001655851,0.00003504644,0.00002363039,0.0004348463,0.003101881,0.00001227799,0.006460242,0.9887552],"study_design_scores_gemma":[0.0007928958,0.0002871183,0.000002353463,0.0006230549,0.0005216058,0.0002012974,0.0000109344,0.00002143559,0.0003214803,0.000004385852,0.9967666,0.0004468047],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003319428,0.9951825,0.00008362588,0.00006788412,0.001223938,0.0005852897,0.0000435645,0.00002093075,0.002460304],"genre_scores_gemma":[0.0002188198,0.9899648,0.0006679524,0.000121632,0.006013471,0.0001379391,0.001176584,0.00009953101,0.001599289],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9903064,"threshold_uncertainty_score":0.9997773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3156107342","doi":"10.2217/fon-2021-0284","title":"Health-Related Quality of Life and Pain with Selinexor in Patients with Advanced Dedifferentiated Liposarcoma","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Karyopharm Therapeutics","keywords":"Medicine; Quality of life (healthcare); Liposarcoma; Intensive care medicine; MEDLINE; Pathology; Nursing; Sarcoma","authors":[{"name":"Mrinal M. Gounder","is_ca":false},{"name":"Albiruni R. Abdul Razak","is_ca":true},{"name":"Adrienne M. Gilligan","is_ca":false},{"name":"Hoyee Leong","is_ca":false},{"name":"Xiwen Ma","is_ca":false},{"name":"Neeta Somaiah","is_ca":false},{"name":"Sant P. Chawla","is_ca":false},{"name":"Javier Martín‐Broto","is_ca":false},{"name":"Giovanni Grignani","is_ca":false},{"name":"Scott M. Schuetze","is_ca":false},{"name":"Bruno Vincenzi","is_ca":false},{"name":"Andrew J. Wagner","is_ca":false},{"name":"Bartosz Chmielowski","is_ca":false},{"name":"Robin L. Jones","is_ca":false},{"name":"Jatin J. Shah","is_ca":false},{"name":"Sharon Shacham","is_ca":false},{"name":"Michael Kauffman","is_ca":false},{"name":"Richard F. Riedel","is_ca":false},{"name":"Steven Attia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01391288335984998,"gpt":0.2891460225004868,"spread":0.2752331391406368,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002502519,0.0001514042,0.0007752457,0.00007182647,0.00002983018,0.000002911946,0.00002986531,0.000131308,0.00006000094],"category_scores_gemma":[0.0001111212,0.00009761401,0.00003155086,0.0002755175,0.0000611226,0.00002682586,0.00002355109,0.0001806231,0.000001302514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001249009,"about_ca_system_score_gemma":0.0004406741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001410438,"about_ca_topic_score_gemma":0.00213925,"domain_scores_codex":[0.9984215,0.0004519889,0.0004505976,0.0002870918,0.0001708067,0.0002179641],"domain_scores_gemma":[0.9989707,0.0002279914,0.0002365652,0.0002117385,0.0001847333,0.0001682158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002230525,0.002935562,0.9418656,0.0001305407,0.000187932,0.00008388367,0.0003329318,0.000001947817,0.00002926827,0.0001111368,0.0002054657,0.05188516],"study_design_scores_gemma":[0.0171784,0.003938365,0.9769439,0.0001473944,0.00004668042,0.00001672682,0.0003880877,0.00000974358,0.00006551741,0.00001596732,0.001156697,0.00009250783],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868395,0.003569974,0.00001157149,0.008899785,0.00007870427,0.0004610207,0.00001721323,0.00002174986,0.0001004539],"genre_scores_gemma":[0.9958372,0.0001688106,0.002332697,0.001301765,0.00003789203,0.00003983919,0.0002449404,0.00001716277,0.00001968169],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05179266,"threshold_uncertainty_score":0.3980584,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2955934677","doi":"10.2217/fon-2019-0010","title":"Utilization of Tumor Genomics in Clinical Practice: An International Survey among ASCO Members","year":2019,"lang":"en","type":"article","venue":"Future Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"American Society of Clinical Oncology","keywords":"Medicine; Context (archaeology); Family medicine; Clinical Practice; Clinical trial; Clinical Oncology; Precision medicine; Personalized medicine; Internal medicine; Cancer; Pathology; Bioinformatics","authors":[{"name":"Romualdo Barroso‐Sousa","is_ca":false},{"name":"Hao Guo","is_ca":false},{"name":"Piyush Srivastava","is_ca":false},{"name":"Ted A. James","is_ca":false},{"name":"Walter Birch","is_ca":false},{"name":"Lillian L. Siu","is_ca":true},{"name":"William P. Tew","is_ca":false},{"name":"Sara M. Tolaney","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02515914198445162,"gpt":0.3726269263304013,"spread":0.3474677843459497,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008631948,0.0000908532,0.0001981288,0.00004790565,0.00001138011,0.000009172167,0.0002158522,0.0002420181,0.00007998779],"category_scores_gemma":[0.0005840034,0.00009565257,0.00005331665,0.00006752054,0.00006404735,0.00001011345,0.00009818825,0.000135297,0.000007899733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006575064,"about_ca_system_score_gemma":0.0003390722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002553751,"about_ca_topic_score_gemma":0.004140005,"domain_scores_codex":[0.9988725,0.0002190674,0.0004041562,0.0002913349,0.00008059038,0.0001323219],"domain_scores_gemma":[0.9990888,0.000136146,0.0002620009,0.0002746779,0.0001790983,0.00005927224],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001172657,0.0006171712,0.9696184,0.00001327666,0.00009305069,0.000014424,0.000154858,0.0008285463,0.00934821,0.0008998052,0.002864768,0.01437478],"study_design_scores_gemma":[0.001168309,0.0008341852,0.6191892,0.000004111957,0.00001246612,0.00001177832,0.0002960735,0.0003894363,0.001696142,0.00002048753,0.3762587,0.0001191205],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908731,0.0001838908,0.000079725,0.0001670626,0.002265868,0.0001953146,0.00006237053,0.000003102662,0.006169572],"genre_scores_gemma":[0.9950373,0.001020487,0.001711285,0.0007185976,0.0007874127,0.000007135148,0.0006180326,0.00001702963,0.00008274754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3733939,"threshold_uncertainty_score":0.3900599,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167775617","doi":"10.1517/14796694.1.2.149","title":"Zoledronic Acid: Past, Present and Future Roles in Cancer Treatment","year":2005,"lang":"en","type":"review","venue":"Future Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Breast cancer; Prostate cancer; Bone resorption; Bone metastasis; Osteoclast; Oncology; Multiple myeloma; Bone Density Conservation Agents; Cancer; Internal medicine; Bone disease; Clinical trial; Osteoporosis; Bone density","authors":[{"name":"Fred Saad","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04450800730881063,"gpt":0.4202681500177839,"spread":0.3757601427089733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009310019,0.0006088064,0.002730549,0.0002657516,0.0000674829,0.000008498468,0.00008643871,0.001191474,0.0003288126],"category_scores_gemma":[0.000001647004,0.0003859465,0.0002733637,0.0002228914,0.00005941186,0.00003551125,0.00004869456,0.0006413567,0.00007926224],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00258022,"about_ca_system_score_gemma":0.002009675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002864654,"about_ca_topic_score_gemma":0.003376681,"domain_scores_codex":[0.9977223,0.0002257067,0.0006203774,0.0006349733,0.0001595224,0.0006371623],"domain_scores_gemma":[0.9988252,0.00006842741,0.0002863009,0.0003954652,0.00003064217,0.0003939731],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009455387,0.000679548,0.0002584866,0.003038527,0.0003463733,0.000460137,0.00017413,6.847188e-8,4.346158e-8,0.00003146431,0.005811478,0.9891052],"study_design_scores_gemma":[0.003549161,0.001460255,0.0007617091,0.001753897,0.00176616,0.0006231959,0.00006259012,8.744077e-7,2.597699e-7,0.000004232735,0.9897897,0.0002279896],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006003323,0.9807364,1.074569e-7,0.01368392,0.001050644,0.002143257,0.00009031226,0.0000444921,0.00219084],"genre_scores_gemma":[0.00001047982,0.9787143,0.0002002719,0.0004591068,0.01685124,0.001446874,0.0003023903,0.00006705129,0.001948319],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9888772,"threshold_uncertainty_score":0.9998593,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3134053447","doi":"10.2217/fon-2020-1210","title":"Role of Cedazuridine/Decitabine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia","year":2021,"lang":"en","type":"review","venue":"Future Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Decitabine; Medicine; Chronic myelomonocytic leukemia; Azacitidine; Myelodysplastic syndromes; Oncology; International Prognostic Scoring System; Internal medicine; Pharmacology; Bone marrow; DNA methylation","authors":[{"name":"Swapna Thota","is_ca":false},{"name":"Aram Oganesian","is_ca":false},{"name":"Mohammad Azab","is_ca":false},{"name":"Elizabeth A. Griffiths","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02505678783195882,"gpt":0.3489397337048004,"spread":0.3238829458728416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008780507,0.000483328,0.003488232,0.000552112,0.00003852144,0.000008840148,0.0005622086,0.0007482776,0.0002009206],"category_scores_gemma":[0.00006532305,0.0003149168,0.0003687743,0.001173906,0.0003082468,0.00003808419,0.0004308884,0.001373516,0.00002534859],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003281869,"about_ca_system_score_gemma":0.004057892,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000330808,"about_ca_topic_score_gemma":0.00003989776,"domain_scores_codex":[0.9966464,0.0005530251,0.001132287,0.0006116252,0.0005014153,0.0005552675],"domain_scores_gemma":[0.9976426,0.0007143233,0.000501074,0.0008983252,0.0001208112,0.0001229074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000802444,0.0001895516,0.000007618969,0.06405232,0.001137429,0.003545107,0.0002514895,0.000002724602,0.00001887444,0.003360167,0.001035623,0.9263188],"study_design_scores_gemma":[0.002109753,0.001408355,0.0004555416,0.01506143,0.002444783,0.005328168,0.0009101006,0.0000282181,0.00000461927,0.00004461825,0.971975,0.0002293921],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001576427,0.9908758,0.000005043049,0.000299496,0.0002017093,0.001912002,0.00003760152,0.00001347138,0.005078492],"genre_scores_gemma":[0.001127234,0.9966202,0.0007376362,0.00004667026,0.000440043,0.0002886355,0.0002019884,0.00006770244,0.0004699182],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9709394,"threshold_uncertainty_score":0.9999303,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3049532301","doi":"10.2217/fon-2020-0573","title":"POLARIS: a Prospective, Multicenter, Noninterventional Study Assessing Palbociclib in Hormone Receptor-Positive Advanced Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Future Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Pfizer","keywords":"Palbociclib; Medicine; Metastatic breast cancer; Oncology; Internal medicine; Clinical trial; Breast cancer; Hormone receptor; Cancer; Clinical Practice; Gynecology; Family medicine","authors":[{"name":"Debasish Tripathy","is_ca":false},{"name":"Joanne L. Blum","is_ca":false},{"name":"Gabrielle B. Rocque","is_ca":false},{"name":"Aditya Bardia","is_ca":false},{"name":"Meghan Karuturi","is_ca":false},{"name":"Joseph C. Cappelleri","is_ca":false},{"name":"Yuan Liu","is_ca":false},{"name":"Zhe Zhang","is_ca":false},{"name":"Keith L. Davis","is_ca":false},{"name":"Yao Wang","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.015351142844713,"gpt":0.3512074246991336,"spread":0.3358562818544206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001815956,0.0002992125,0.0006873491,0.0001141445,0.00009224335,0.00002250998,0.0001495099,0.0001809534,0.0004789834],"category_scores_gemma":[0.00004998191,0.000270927,0.0001371587,0.0004733921,0.000114295,0.0003418748,0.0001051978,0.0007560981,0.00003273169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001120697,"about_ca_system_score_gemma":0.000346346,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001046024,"about_ca_topic_score_gemma":0.0003047935,"domain_scores_codex":[0.9979001,0.000251102,0.0004651863,0.0006530354,0.0002943464,0.0004361869],"domain_scores_gemma":[0.9990193,0.00008219909,0.0002455208,0.0001859761,0.0002442921,0.0002227056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0207486,0.005340725,0.682323,0.0001285092,0.0008172753,0.0006154205,0.01529354,0.00006234835,0.05188759,0.0001750417,0.0007237517,0.2218842],"study_design_scores_gemma":[0.0209542,0.002313231,0.9533736,0.0002352225,0.0001165743,0.0001089442,0.01313675,0.0001097296,0.0004446529,0.0000290915,0.008897285,0.0002807005],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.957333,0.005618417,0.000742047,0.03213977,0.0008703047,0.00227821,0.0001816649,0.0001764674,0.0006600806],"genre_scores_gemma":[0.9921721,0.0001172799,0.003724603,0.001835209,0.001589464,0.0003713323,0.00003262313,0.00005875043,0.00009869035],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2710506,"threshold_uncertainty_score":0.9999743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}